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USE OF NON-OPIOID ANALGESICS AS FIRST LINE TREATMENT FOR 
ACUTE PAIN MANAGEMENT BY EMERGENCY MEDICAL SERVICES 
PROVIDERS 
STEVEN KIYOHIKO SHIBA 
ABSTRACT 
 Pain is the universal symptom of illness and trauma. It affects people of all ages, 
cultures, and backgrounds, causing distress and suffering. Appearing in a plethora of 
diagnoses, almost all patients will experience some type of pain as a related symptom 
during their lifetime. The ubiquitous nature of pain renders it likely that a wide variety of 
healthcare providers will treat patients reporting pain in both the acute care and 
longitudinal settings. Many institutions and governing bodies in the medical sphere have 
emphasized the duty of the medical field to treat pain and thereby alleviate suffering.   
It is common for Emergency Medicine (EM) physicians to manage patients 
presenting to the Emergency Department (ED) in pain. Although these patients’ 
etiologies for their pain may differ, most will be experiencing pain from an acute insult. 
Emergency Medical Services (EMS) is the extension of EM into the prehospital setting. 
As such, EMS providers interact with many of the same patients experiencing acute pain. 
Despite the prevalence of pain and the importance of alleviating it, acute pain 
management has often been inadequate. Improving pain management should continue to 
be a high priority. 
Opioid analgesics have long been the standard of care for acute pain management. 
The first opiate, morphine, was isolated in the early 1800’s. Opioids are potent analgesics 
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and are titratable to effect. However, they have a significant adverse effect profile. 
Among other adverse effects, opioids can cause hypotension and respiratory depression. 
In addition, the United States opioid epidemic has placed increased pressures on EMS 
and the entire healthcare profession to utilize opioid alternatives while continuing to 
improve the quality of acute pain management provided to patients. As a result, non-
opioid analgesics have gained increased attention and use in EMS. They generally have 
fewer adverse effects than opioids and are not typically associated with a potential for 
addiction and abuse. However, the individual and subjective nature of the pain experience 
increases the difficulty of achieving improved analgesia.  
EMS providers must weigh these various factors and the complexity of the 
pain experience when determining the most appropriate treatment for acute pain. 
This review seeks to determine if non-opioid analgesics have potential for use as 
first line treatment by EMS over opioid analgesics, the standard of care for acute 
pain management. The purpose of this review of the current literature, especially 
comparison studies, is to investigate the common EMS analgesics: morphine, 
fentanyl, acetaminophen, ketorolac, ibuprofen, nitrous oxide, methoxyflurane, and 
ketamine. The findings are discussed in relation to four important outcome 
measures identified: effect on pain severity, rescue analgesic use, patient 
satisfaction, and the consideration of risks. Due to the paucity of research on this 
important topic, a general recommendation cannot be made for the use of non-
opioid analgesics as first line treatment for acute pain management by EMS. 
However, this review provides several specific suggestions regarding the use of non-
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opioid analgesics as first line treatment by EMS. Applicability concerns are 
addressed, and a protocol is presented that EMS could use to adapt the findings to 
existing protocols.  
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INTRODUCTION 
 Pain is a vital topic in medicine. It does not discriminate, affecting people of all 
ages, cultures, and backgrounds. Regardless of the diagnosis, most all patients will 
experience some type of pain as a related symptom during their lifetime. In her article, A 
Capsule History of Pain Management, Dr. Meldrum wrote of pain as the first medical 
complaint (Meldrum, 2003). This statement highlights the long-standing relationship that 
society has with pain.  
 Many different medical providers encounter patients reporting pain as a symptom. 
Within the field of Emergency Medicine (EM), pain remains a common complaint. 
Accounts of pain prevalence in the Emergency Department (ED) vary from 38% to 
61.2% and 78% (Cordell et al., 2002; Smith et al., 2015; Todd et al., 2007). EM often 
deals with acutely sick an injured patients.  
Another group of medical providers care for a similar patient population. Now 
common throughout the world, Emergency Medical Services (EMS) is the extension of 
the ED into the prehospital setting. While there is a facet of EMS that performs other 
transport duties, such as interfacility transports between healthcare facilities, only the 
prehospital emergency response and transport of sick and injured patients to the ED will 
be considered as “EMS” for this review. Prehospital critical care units, both ground and 
air-based exist and may have expanded scopes of practice based on their provider system. 
They less commonly provide initial prehospital care and will be excluded from this 
project. 
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A survey conducted in 2013 found that approximately 17% of ED patients are 
brought in by EMS (Augustine, 2014). According to a 2009 United States national 
estimate, there were approximately 28 million EMS transports in that year (Federal 
Interagency Committee on Emergency Medical Services, 2012). EMS allows for early 
medical intervention and transport of sick and injured patients in the prehospital setting to 
the ED. The capabilities of each EMS system can vary widely based on provider scope of 
practice and department policies.  
The three most common provider levels present on an EMS team in the United 
States are Emergency Medical Technician (EMT), Advanced EMT (AEMT), and 
Paramedic. The EMT is trained to perform the most basic and least invasive assessments 
and interventions in prehospital care. This includes select medication administration, via 
the oral (PO – “per os”) and buccal routes, that varies slightly from state to state (U.S. 
Department of Transportation National Highway Traffic Safety Administration, 2007). 
There is also limited use of the intramuscular (IM) route by EMTs in certain situations 
such as anaphylaxis. Many states are now permitting intranasal (IN) administration of 
naloxone for overdose by EMTs. According to these national standards, EMTs are 
limited to non-pharmacologic treatment of pain (U.S. Department of Transportation 
National Highway Traffic Safety Administration, 2007). However, there are exceptions. 
Vermont, as an example, has expanded the EMT scope of practice to include PO 
administration of acetaminophen for pain management (Vermont Department of Health 
Office of Public Health Preparedness and Emergency Medical Services, 2018). The 
AEMT expands on the scope of the EMT by including intravenous (IV) and intraosseous 
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(IO) route of administration in addition to other skills and medications (such as nitrous 
oxide for pain) not available to an EMT (U.S. Department of Transportation National 
Highway Traffic Safety Administration, 2007). The Paramedic is the most advanced level 
and can administer all the pain medications discussed in this thesis if they are available 
for use.  
There are other organizational differences in EMS. As an example, some 
organizations are privately owned, while others are a municipal third service and are a 
part of the government provided services. Yet other services are hospital owned and run. 
Despite the differences in EMS organizations and provider levels, all EMS providers 
have the same responsibilities to care for and appropriately treat their patients as every 
other medical provider. This includes the management of their patients’ pain.  
There are limited amounts of published reports on the prevalence of pain in the 
prehospital setting. One study in Paris found that 42% of EMS patients reported acute 
pain (Galinski et al., 2010). Another study in Australia reported 53% of EMS patients in 
their study reported pain (Lord, Cui, & Kelly, 2009). These numbers are within the range 
found by the previous studies investigating the prevalence of pain in the ED. The 
National Association of EMS Physicians and the American College of Emergency 
Physicians (ACEP) also acknowledged the high occurrence of pain reported by patients 
who call 9-1-1 for EMS services (American College of Emergency Physicians, 2016; 
Gunderson, 2011). With such high occurrences of pain in the ED and EMS settings, the 
importance of pain management increases.  
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Pain management has often been found to be inadequate (Albrecht et al., 2013; 
American College of Emergency Physicians, 2016; Baker, 2017; Brennan, Carr, & 
Cousins, 2016; Campbell, 1996; Galinski et al., 2010). The inadequacy of pain 
management was such an important issue that in the American Pain Society 1995 
Presidential Address, Dr. Campbell suggested elevating the importance of pain by 
considering it the “fifth vital sign” (Campbell, 1996). In concept, this was an excellent 
way to increase awareness and promote better pain management. While it succeeded in 
raising awareness and causing policy changes, much critique has been made about 
regarding pain as a vital sign (Frieden, 2016; Levy, Sturgess, & Mills, 2018; Morone & 
Weiner, 2013). One study specifically reported that frequent assessment of pain, as would 
be done for other vital signs, did not result in improved pain management (Mularski et 
al., 2006, p. 5). Awareness without action does not improve care. However, the 
shortcomings of the call to consider pain a vital sign should not diminish the importance 
of pain management in medicine.            
Many institutions including the Institute of Medicine and the American Medical 
Association have pointed to the ethical, moral, and professional duty of healthcare 
providers to alleviate suffering through the management of patients’ pain (American 
Medical Association, n.d.; Pizzo & Clark, 2012). In a policy statement, the ACEP also 
stated that pain management should be provided by EMS systems (American College of 
Emergency Physicians, 2016). The World Health Organization and the United Nations 
went one step further and declared adequate pain management a human right (Brennan et 
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al., 2016). With so many large and prominent organizations making these statements, 
pain management should be a priority in medicine and within EMS.      
Thus far, pain and the importance of pain management have been discussed and 
placed into the context of EMS. Inadequacies have been highlighted and the need for 
continued improvements in prehospital pain management are evident. The remainder of 
the introduction will describe the different aspects of pain management as it pertains to 
EMS. Topics will include: a brief review of the pain experience, pain assessments, the 
appropriate identification of treatment goals, and treatment options. 
 
Describing the Pain Experience 
Looking beyond the intuitive understanding of pain, it is important to ask: What is 
pain? Is it the physical stimulation of nerve endings by various inputs, or the learned 
response to injury, or something else entirely? The International Association for the 
Study of Pain defines pain as “an unpleasant sensory and emotional experience associated 
with actual or potential tissue damage, or described in terms of such damage” and also 
notes that all pain is subjective (International Association for the Study of Pain, 2018). 
The experience of pain is not just a stimulation of nerves or a learned response to injury. 
With this definition, it can be understood that pain is a complex and individual 
experience.  
 Pain is an ambiguous term. When considering the acute pain experience, it is 
useful to identify three broad categories: signal input, descending modulation, and 
perception. There are four main processes involved in the entire pain experience: 
 6 
transduction, transmission, perception, and descending modulation. In terms of normal 
pain signal input, an external or internal noxious stimulus begins the nociception 
pathway. The recognition of a noxious stimulus by a nociceptor is known as transduction. 
The second process of pain signal input is transmission; the process by which the neural 
signal is carried from the afferent nociceptor, through the Dorsal Horn, and terminating in 
various regions of the brain including the Thalamus. This concludes the process of signal 
input after a noxious stimulus. 
 The descending modulation process is a more recently discovered part of the pain 
pathway (Institute of Medicine (US) Committee on Pain, Osterweis, Kleinman, & 
Mechanic, 1987). As its name implies, it is a pathway that originates in the brain and acts 
in the Dorsal Horn region of the spinal cord. Descending modulation signals work on the 
transmission pathway to inhibit the process of signal input. One of the ways this is 
achieved is by the release of endogenous opioid-like substances (Ropper, Samuels, & 
Klein, 2014). Descending modulation affects both the signal input and perception of pain.  
 Unlike signal input and modulation, the perception of pain is a subjective process. 
The science underlying pain perception is not entirely understood (Ropper et al., 2014).  
However, research is beginning to unravel subjective aspect of pain perception. Dr. 
Coghill published an article highlighting various aspects of this subjectivity. Among 
them, the article mentions that brain imaging has observed patterns that coincide with 
individual differences in pain perception (Coghill, 2010). In addition, several factors that 
contribute to the patient’s perception of pain were listed. These include: genetics, 
sociological factors, attention given to the painful stimulus, prior experiences and 
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expectations, and other personality and behavioral factors such as anxiety (Coghill, 
2010). All these factors can lead to differences in sensitivity, pain tolerance, and the 
patient’s overall response to pain.  
 While the pain pathway is an important aspect of understanding the pain 
experience, there are also some other ways of classifying pain. Pain can be classified by 
duration. Acute pain occurs over a relatively short time period and typically occurs as a 
result of an acute injury (traumatic or medical in nature). In contrast, chronic pain occurs 
over an extended period. Pain can also be classified according to location. Visceral pain 
refers to pain that originates from the internal organs. It is not easily localized and may 
result from inflammation or other etiologies. Pain located in the integumentary or 
musculoskeletal systems is referred to as somatic pain and is typically well-localized.  
The etiology resulting in a patient presenting to EMS or the ED with pain may 
vary. Despite the differences in etiology, most patients in these two settings are 
experiencing pain from an acute insult. One study found that 70.7% of patients reported 
acute pain in the ED (Mura et al., 2017). Chronic pain is also important. However, it is 
less prevalent than acute pain in EMS and the management of chronic pain requires a 
different approach. Since acute pain is more prevalent, it will be the focus of this 
literature review. 
 The patient’s pain experience is certainly complex and influenced by many 
factors. There are also many aspects of pain that are not fully understood. However, it is 
important that EMS providers (and all healthcare providers) understand the many factors 
that influence a patient’s pain experience. This will result in pain management that is 
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tailored to each patient and ideally leads to better outcomes. To achieve improved 
outcomes, providers must be proficient in recognizing and assessing a patient’s pain. 
 
Assessment of Pain 
 The first step in pain management is to adequately assess the patient’s pain. Acute 
pain may cause changes in the autonomic nervous system resulting in seemingly 
objective signs such as tachypnea, tachycardia, and hypertension. However, these signs 
are not a reliable measure of the presence of or intensity of pain that a patient is 
experiencing (Bossart, Fosnocht, & Swanson, 2007; Ducharme, 2016; Jennings, 
Cameron, & Bernard, 2009; Marco, Plewa, Buderer, Hymel, & Cooper, 2006). Due to the 
lack of correlation between these objective measures and pain, other forms of assessment 
must be utilized.  
 Each patient will have their own unique experience with pain. As a result of the 
individual and subjective nature of pain, the patient’s own report of their pain should be 
the central factor influencing pain assessment and should drive the entire pain 
management process (American College of Emergency Physicians, 2010, 2017; 
Ducharme, 2016; Gunderson, 2011; Jennings et al., 2009; Maio et al., 2002). One 
important element of a patient reported assessment is the severity of the pain. Pain scales 
are a commonly used tool to assess initial pain severity and the change in severity 
throughout the pain management process. Although many different versions of pain 
scales exist, a few of the more common and recommended ones for EMS will be 
discussed.     
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 The Numerical Rating Scale (NRS) is commonly used in the prehospital setting. It 
has also been recommended as one of the pain scales best suited for EMS (Jennings et al., 
2009; Maio et al., 2002). The NRS asks the patient to rate their pain on a scale of zero (no 
pain) to ten (worst pain). The range can also be expanded to a scale of 0-100 to increase 
sensitivity (Maio et al., 2002). Although the scale is often performed verbally, it can also 
be administered on a physical pain scale card. The verbal administration of the NRS is 
well suited to EMS as it is easy to administer and does not require a physical pain scale 
card.  
 There are several other verbal based pain scales. Another one recommended for 
EMS is the Adjective Response Scale (ARS) (Maio et al., 2002). It consists of several 
adjectives that indicate varying levels of pain intensity. For example, the patient might be 
asked to choose between “none”, “slight”, “moderate”, “severe”, and “agonizing” (Maio 
et al., 2002). The number of categories and the specific adjectives used can be changed. 
A 4-point Verbal Response Scale (VRS) is similar in nature to the ARS and consists of 
four words describing the intensity of the pain. Both scales, while easy to administer in 
the field, can pose a language barrier. They also limit the number of possible responses, 
which decreases sensitivity.   
 The various verbal scales mentioned so far require adequate language knowledge 
and require the patient to have the capacity to understand the prompts and respond 
appropriately. Young pediatric patients may not be able to appropriately rate their pain 
when using those scales. There are two other common types of scales that are more 
appropriate in this age group. The first are various scales that utilize illustrations or 
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pictures of faces expressing various levels of pain. These faces may be accompanied by 
numbers or descriptive words. The assessment is explained to the child and the child is 
asked to select the face that corresponds with the level of pain the child is experiencing.  
 The second common type of scale, an observational based scale, for pediatrics is 
particularly useful in patients who are unable to report their own pain utilizing other 
scales. It is in this case that healthcare providers must rely on other observational means 
of pain assessment. The FLACC Scale is an example of this type of scale. It utilizes five 
different categories (Face, Legs, Activity, Cry, Consolability) which are rated as 0, 1, or 2 
based on descriptions provided in the scale (Merkel, Voepel-Lewis, Shayevitz, & 
Malviya, 1997). Observational based scales provide a framework and scoring system to 
aid in the assessment of pain.  
 A final pain scale, though not commonly used in EMS, is important to mention 
due to its prevalent use in research studies. The Visual Analogue Scale (VAS) consists of 
a vertical or horizontal line that is usually 10-cm in length (Jennings et al., 2009). Either 
end of the line is marked with an additional perpendicular line and words indicating 
which side means no pain and which means the worst pain. The patient is asked to mark 
where on the line they would rate their pain.  
 Pain scales are important tools; however, they are only one aspect of a 
comprehensive pain assessment. It is important to note that pain scale scores shouldn’t be 
taken as an absolute value. Because of the subjective nature of pain, a 6 on the NRS, for 
example, will mean different things for each individual patient. Pain scales are most 
useful for tracking the progress of pain in the same patient. Other assessments are needed 
 11 
to gain a full picture of the pain the patient is experiencing and to adequately manage 
each patient’s pain (American College of Emergency Physicians, 2017). Simply asking 
the patient whether or not more analgesics are required is extremely beneficial 
(Ducharme, 2016). Other important assessments include location, quality, radiation, 
provocation, alleviation, and function. 
 
Goal of Pain Management 
 Determination of a pain management goal is an essential aspect of the pain 
management process. A goal defines what is needed for a treatment to be considered 
successful. Treatment without a desired outcome is futile. The ethical principles of 
respect for autonomy, non-maleficence, and beneficence all play important roles in the 
goal making process.  
 For some forms of treatment, a universal goal may be applied for all patients. The 
initial goal of resuscitative measures in cardiac arrest could fairly be set as achieving 
return of spontaneous circulation. Studies investigating analgesic efficacy may set goals 
such as achieving no pain, achieving a reduction below a certain preset point on a pain 
scale, or a percentage decrease in pain as a universal outcome for all patients in the study 
(Mehta, 2015). However, with an issue as subjective and individual as pain management, 
a universal goal may not be appropriate.  
 The most appropriate pain management goal is one that is specific to each patient 
(American College of Emergency Physicians, 2017). While this approach does not allow 
for a rigid definition of an ideal goal, there are some important recommendations that can 
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act as a reference when defining a patient’s pain management goal. The first is to include 
the patient in the decision making process (Lee, 2016; The Joint Commission, 2017; 
University of Wisconsin Health Pain Care Services, n.d.). This intuitively makes sense 
given the subjective nature of pain. A study investigating patients’ perspectives on acute 
pain management found that patients desire open communication and involvement in the 
decision making process; patients also prefer to discuss how their pain is affecting them 
functionally as opposed to solely relying on a pain score (Smith et al., 2015). Involving 
patients in their own care also applies the principle of respect for autonomy.  
 The next recommendation is that zero pain should not be the goal of pain 
treatment (Gunderson, 2011; Lee, 2016; University of Wisconsin Health Pain Care 
Services, n.d.). A goal of zero pain is unrealistic, may not be possible, and would likely 
involve extensive analgesia to the point that the risks of their use begin to far outweigh 
the benefit of achieving the goal. The Joint Commission and other organizations 
emphasize the importance of realistic goal setting in pain management (Lee, 2016; The 
Joint Commission, 2017; University of Wisconsin Health Pain Care Services, n.d.). 
Alleviating some of the patient’s suffering may be a successful outcome in a major 
trauma patient. It is important to discuss realistic goal setting with the patient.  
Realistic goal setting is not only important in the context of adequate pain 
management, it also has implications for healthcare reimbursement. Patient satisfaction 
scores are now used as a metric to determine the amount of reimbursement received 
(Mehta, 2015). This specific topic is too large in scope to be fully considered here. In 
short, a patient presenting to EMS or the ED with the unrealistic expectation that their 
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pain should be eliminated will not only be less likely to consider any level of realistic 
pain management as adequate, they are also likely to negatively impact reimbursement 
due to not understanding what should be expected out of pain management. Due to 
unrealistic expectations, these patients may also formally submit a complaint to the Board 
of Medicine or the Office of Emergency Medical Services, in the case of EMS. In 
contrast, a patient who comes to a realistic goal regarding pain management after 
discussing the topic with the provider may be more likely to be satisfied by the level of 
care provided and less likely to formally submit complaints. These are other important 
reasons to discuss realistic goal setting with patients. 
Goals may also progress or change over time. For example, in the hours following 
a trauma that requires admission to the hospital, simply achieving tolerable pain with no 
movement may be the first goal. As healing progresses, the goal may adjust to tolerable 
pain during physical therapy. This type of goal setting aligns with the recommendations 
and patient preference for functional goal setting (American College of Emergency 
Physicians, 2017; Smith et al., 2015; The Joint Commission, 2017; University of 
Wisconsin Health Pain Care Services, n.d.).  Following this recommendation allows the 
healthcare provider to better balance the principles of beneficence and nonmaleficence 
with the goal of alleviating suffering.  
One final note about acute pain management goal setting is that the patient’s 
and/or the healthcare provider’s desire to avoid certain risks or symptoms associated with 
a possible analgesic choice is a valid aspect of the goal. As with any treatment decision, 
the risks must be weighed against the benefits. Utilizing these recommendations will aid 
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the patient and healthcare provider in making the most appropriate goal for the patient’s 
acute pain management. 
 
Non-Pharmacologic and Alternative Pain Treatments 
 There are many forms of treatment to alleviate acute pain. Non-pharmacologic 
treatments are readily available to all levels of EMS providers. Among the options are the 
use of hot and cold packs (Ducharme, 2016). The heat may be soothing, and the ice may 
help to reduce inflammation. Immobilization and elevation of injured limbs are other 
procedures that may alleviate pain or prevent further pain from movement. As previously 
mentioned, there are many behavioral and emotional factors that contribute to a patient’s 
pain (Coghill, 2010). In the prehospital setting, techniques such as distraction and 
relaxation may help to combat these factors and play a role in pain management.  
 In addition to the common non-pharmacological pain management treatments 
utilized in EMS, there are several alternative treatments that have been used in settings 
outside of EMS. There have been studies demonstrating the efficacy of intensive 
cryotherapy, aromatherapy, acupuncture, and transcutaneous electrical nerve stimulation 
in pain management (Ayan et al., 2012; Ducharme, 2016; Fan et al., 2017; Kline, 2017). 
 There is one final acute pain treatment option that has potential for use in the 
prehospital setting. That is, the use of nerve blocks by EMS in specific cases of acute 
pain. A study in Australia investigated the feasibility and efficacy of a fascia iliaca 
compartment block administered by EMS in the prehospital setting (McRae, Bendall, 
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Madigan, & Middleton, 2015). They found that the procedure can be effectively 
performed by paramedics in their setting.  
 
Pharmacologic Pain Treatments: Opioids and Non-Opioids 
 The pharmacologic treatments utilized in the prehospital setting can be placed 
into two broad categories: opioids and non-opioids. Analgesics in each category have 
their advantages and disadvantages. While there are many different opioid and non-
opioid analgesics, only those analgesics that are utilized in the prehospital setting will be 
discussed (Table 1). 
Table 1. Common Opioid and Non-Opioid Analgesics Used in EMS. 
Opioid Analgesics Non-Opioid Analgesics 
Morphine Acetaminophen 
Fentanyl Ketorolac 
 Ibuprofen 
 Nitrous Oxide 
 Methoxyflurane 
 Ketamine 
 
The term opioid is now commonly used to broadly describe any substance that is 
structurally similar to the natural alkaloids found to act on the opioid receptors (National 
Institutes of Health LiverTox, 2018). This encompasses both natural and synthetic 
substances. The umbrella term opioid includes analgesics such as morphine and fentanyl. 
The natural plant alkaloids are derived from Papaver somniferum, the opium poppy. 
Opiate is the term to describe these naturally derived substances (National Institutes of 
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Health LiverTox, 2018). Friedrich Wilhelm Sertürner isolated the first opiate, morphine, 
in 1804; However, the medical use of opiates significantly increased after the invention 
of the hypodermic needle in the mid-19th century (Meldrum, 2003). These substances 
were initially unregulated and available over-the-counter and only after concerns were 
raised regarding abuse was regulation put in place (Meldrum, 2003).  
Opioids quickly became established as the standard of care, especially in acute 
pain management. Morphine is described as the standard from which other analgesics are 
measured against (National Institutes of Health LiverTox, 2018). Given the current 
understanding of the pain pathways discussed in the Describing the Pain Experience 
section, the analgesic efficacy of opioids is not surprising. The opioid receptors are 
located throughout the body including the central nervous system. In terms of the pain 
pathway, opioids produce their analgesic effects by acting on the transmission and 
perception of pain (Siu, 2015). While this doesn’t decrease the transduction of the 
noxious stimulus, it is still extremely effective in pain management.           
 Given that opioids have long been the standard of care for acute pain management 
and indeed, often the only option available to prehospital providers, it is no surprise that 
EMS would adopt opioids as a standard treatment. Morphine and fentanyl are the two 
most common prehospital opioid analgesics. They both have a quick onset of action and 
can be titrated to effect (Ducharme, 2016). Those are both advantages in terms of treating 
acute pain. Fentanyl, a synthetic opioid, is 100 times more potent than morphine 
(Ducharme, 2016). While they are effective in their primary function as an analgesic, 
there are several adverse effects that are disadvantages of their use. The major adverse 
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effects for morphine are nausea, emesis, constipation, respiratory depression, sedation, 
hypotension, and euphoria (Abdel-Aziz & Adams, 2017; Ducharme, 2016). Fentanyl’s 
adverse effects are similar to morphine’s with the notable exception that Fentanyl causes 
less cardiovascular depression (Ducharme, 2016).  
Opioid medications do have a specific, fast-acting antidote typically available to 
healthcare provider. Naloxone is a medication that can be used to reverse the effects of 
opioids in the event of severe adverse effects. It functions at all the opioid receptors as a 
competitive antagonist (Burillo-Putze & Miro, 2016). Naloxone can be administered via 
most routes. However, the ability to administer it via the IN route is very beneficial. This 
allows for rapid administration that does not require the use of needles. It also is 
incredibly safe to use and rarely ever causes serious complications (Burillo-Putze & 
Miro, 2016). The use of naloxone has become commonplace in society and is available to 
the general public (Adams, 2018). This is partly due to its ease of use, relative safety, and 
efficacy in reversing opioid overdoses.  
 Another reason naloxone has become commonplace is related to a different 
disadvantage associated with the use of opioid analgesics: the potential for addiction and 
misuse. Morphine and fentanyl are both Schedule II controlled substances, indicating 
they have a high abuse and dependence potential (United States Drug Enforcement 
Administration, n.d.). The United States opioid epidemic has continued to gain increased 
attention. From 1999 to 2017 there was a 600% increase in opioid overdose deaths (U.S. 
Department of Health and Human Services Centers for Disease Control and Prevention, 
2018). The CDC reports that an average of 130 people in the United States die from an 
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opioid overdose every day (U.S. Department of Health and Human Services Centers for 
Disease Control and Prevention, 2018). This is a large number of deaths each day. 
However, most of the research has focused on the link between opioid prescription and 
subsequent addiction. These studies are typically not in the setting of acute pain 
management. However, some studies have investigated recurrent use or a possible 
contribution to abuse after opioid exposure or prescription in the ED setting including in 
opioid-naïve patients (Butler et al., 2016; Hoppe, Kim, & Heard, 2015). Both studies 
highlighted their limitations and mentioned the need for more research on this topic. 
The exact role that EMS providers may play is less clear. In the EMS setting, 
opioids are administered as intermittent bolus doses. EMS providers do not write 
prescriptions and if pain is being treated, it is almost always acute pain. This is a very 
different scenario compared to prescription opioids leading to addiction, diversion or 
misuse. As described earlier, opioid analgesics have been the standard for acute pain 
management in EMS.   
 In the wake of the opioid epidemic, non-opioid analgesics have gained more 
attention. The push for these alternatives is a result of the possibility for addiction and 
relapse after an exposure to opioids. Non-opioid analgesics have fewer adverse effects 
compared to opioids and are typically not associated with addiction due to differing 
mechanisms of action. While some EMS systems have utilized various non-opioid 
analgesics for decades, others have only more recently began allowing EMS providers to 
administer these treatments (M. Miller & Burstein, 2017; Porter, Dayan, Dickerson, & 
Middleton, 2018). There are also many EMS systems that still do not provide an 
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alternative to opioids for analgesia. The non-opioid analgesics used in the prehospital 
setting that will be discussed are acetaminophen, ketorolac, ibuprofen, nitrous oxide, 
methoxyflurane, and ketamine.  
 Both ketorolac and ibuprofen belong to a class of drugs referred to as nonsteroidal 
anti-inflammatory drugs (NSAIDs). In EMS, ketorolac is administered either IV or IM 
and ibuprofen is administered PO. They act as cyclooxygenase inhibitors and their 
actions effect the signal transduction portion of the pain pathway (Siu, 2015). 
Therapeutically, NSAIDs are particularly useful in acute pain that can be associated with 
inflammation (Abdel-Aziz & Adams, 2017). The main disadvantage of NSAIDs is that 
they have more adverse effects than most of the other non-opioid analgesics. One of 
major adverse effects is their interference with platelets, which increases the risk of 
hemorrhage and GI irritation (Ducharme, 2016). This can be of concern when the insult 
causing pain has resulted in bleeding or if it will require operative management. They can 
also interfere with renal function, though that is more commonly noted in the elderly and 
in patients with preexisting renal diseases or injuries (Ducharme, 2016). NSAIDs are 
contraindicated for use in patients with potential hemorrhaging, renal injury, a suspected 
need for surgery, and in patients who are pregnant (Massachusetts Department of Public 
Health Office of Emergency Medical Services, 2017).  These adverse effects and 
contraindications limit the potential use of NSAIDs in the prehospital setting.  
 Unlike the NSAIDs, acetaminophen can be used in almost any patient. This is an 
advantage when it comes to the selection of analgesics in the prehospital setting. In 
addition to its use as an analgesic, acetaminophen is also an antipyretic. Unlike the 
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previous analgesics, the exact analgesic mechanism of action for acetaminophen is still 
not fully understood (Abdel-Aziz & Adams, 2017). However, it is known not to affect 
platelets and not to have anti-inflammatory affects (Ducharme, 2016). It is also believed 
to act on the signal transduction portion of the pain pathway (Siu, 2015). One 
disadvantage is hepatotoxicity in overdose or in those with other acute or chronic hepatic 
insult. Despite this, patients with mild renal or hepatic impairment can still receive 
acetaminophen (Ducharme, 2016). Only patients with severe hepatic impairment, such as 
liver failure, are contraindicated (Massachusetts Department of Public Health Office of 
Emergency Medical Services, 2017). The relative safety and lack of adverse effects of 
acetaminophen along with its ability to be administered in a wide variety of patients are 
benefits to the use of acetaminophen in EMS.  
 The next two non-opioid analgesics are administered via inhalation. Nitrous 
oxide, which is typically delivered as a mixture of 50% nitrous oxide and 50% oxygen, 
has a fast onset and offset (Ducharme, 2016). The fast onset makes it especially useful for 
acute pain in the prehospital setting. Nitrous oxide is reported to indirectly effect the 
descending modulation portion of the pain pathway (Sanders, Weimann, & Maze, 2008). 
The two primary adverse effects are nausea and emesis (Ducharme, 2016). Due to the 
nature of the gas, nitrous oxide use is contraindicated in patients with head injury or 
altered mental status, or in conditions where there is already air in unwanted body 
compartments such as in a pneumothorax or perforated bowel (Ducharme, 2016). As with 
other analgesics, this can be problematic as such conditions may be difficult to detect in 
the prehospital setting without diagnostic equipment. Two other considerations for its use 
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in the prehospital setting are the additional bulk of carrying another gas tank on the 
ambulance and the ability to effectively ventilate the ambulance to avoid provider 
exposure to the gas. 
 The second inhaled analgesic is methoxyflurane. Although it is not currently 
licensed for use in the United States, this particular analgesic has been in use in Australia 
for several decades (Porter et al., 2018). Methoxyflurane’s analgesic mechanism of action 
is not fully known (National Institutes of Health National Cancer Institute, 2011). 
Although its use as an anesthetic at higher doses resulted in nephrotoxicity, it has not 
been shown to have this affect when used at lower doses as an analgesic (Porter et al., 
2018). In fact, Porter et al. describes high patient satisfaction with its use and minimal 
adverse effects such as dizziness and headache. Like nitrous oxide and other analgesics, 
the onset of action of methoxyflurane is very fast (Porter et al., 2018). One advantage of 
methoxyflurane is that it is administered via a relatively small inhalation device and does 
not require a bulky tank of gas like nitrous oxide. This eliminates a potential barrier to its 
use in the prehospital setting. 
The final non-opioid is sub-dissociative dose or low dose ketamine. Traditionally 
used as an anesthetic, it acts as an analgesic in lower doses (American College of 
Emergency Physicians, 2017). The main mechanism of action is the antagonism of the N-
methyl D-aspartic acid receptor (Kurdi, Theerth, & Deva, 2014). This effects the 
perception and descending modulation portion of the pain pathway. Ketamine is a 
relatively recent addition to civilian EMS analgesia protocols. However, it has been 
recommended in mountain rescue since 1999 and is effectively used in military medicine 
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(Wedmore & Butler, 2017). Ketamine offers many benefits over the opioid analgesics. It 
has minimal effect on respiratory drive and acts as a sympathetic nervous system 
stimulant, which results in increased blood pressure, heart rate, and cardiac output (Kurdi 
et al., 2014). Low dose ketamine has few contraindications including patients under three 
months old, patients with a history of schizophrenia, and cautioned in patients who may 
not tolerate hyperdynamic states (Pourmand, Mazer-Amirshahi, Royall, Alhawas, & 
Shesser, 2017; Wedmore & Butler, 2017). Previous contraindications for head and ocular 
injury patients have been disproven, with the exception of hydrocephalus (Wedmore & 
Butler, 2017). However, ketamine is also associated with adverse effects including 
emergence reactions, hallucinations, dizziness, nausea, emesis, sedation, hypersalivation, 
and laryngospasm (Ducharme, 2016; Kurdi et al., 2014; Motov, Mai, et al., 2017; 
Wedmore & Butler, 2017). The most dangerous adverse effect, laryngospasm, was found 
to only occur in 0.3% of cases in one study investigating the adverse effects of ketamine 
used for sedation (Green et al., 2009). Notably, the median dose in this study is 
approximately four times higher than the doses recommended for low dose ketamine.  
Ketamine also has a disadvantage compared to the other non-opioids because it is 
a Schedule III controlled substance, which means it has abuse potential (United States 
Drug Enforcement Administration, n.d.). In a policy statement, ACEP recognizes the 
efficacy and potential benefit of ketamine as an analgesic when compared to opioid 
analgesics (American College of Emergency Physicians, 2017). However, it is noted that 
more randomized clinical trials are needed to better define how to most appropriately 
utilize ketamine in this setting. There are also many administrative and political hurdles 
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that would need to be overcome in order for ketamine to be used as an analgesic 
(American College of Emergency Physicians, 2017). Due to these challenges and 
drawbacks, ketamine will be considered separately from the other non-opioid analgesics. 
Overall, each of the prehospital analgesics presented have their own set of risks and 
benefits that must be considered when determining the appropriate treatment for each 
individual patient (Table 2). 
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Table 2. Advantages and Disadvantages of Prehospital Analgesics. Table highlighting 
the main advantages and disadvantages for each of the analgesics discussed as it pertains 
to EMS. 
 Advantages Disadvantages 
Morphine 
Fast onset 
Can be titrated to effect 
Easy reversal with naloxone 
Long standing standard of 
care for acute pain 
Numerous adverse effects (nausea, 
emesis, constipation, euphoria, and 
sedation) 
Respiratory depression 
Hypotension 
Schedule II controlled substance 
Opioid analgesic 
Fentanyl 
See morphine 
100 times more potent than 
morphine 
See morphine 
Less cardiovascular depression 
compared to morphine 
Ketorolac 
NSAID - Anti-inflammatory 
property useful for pain 
associated with inflammation 
Non-opioid analgesic 
Platelet interference - increased risk 
of hemorrhage and GI irritation 
More adverse effects and 
contraindications than other non-
opioids 
Ibuprofen See ketorolac See ketorolac 
Acetaminophen 
Usable in almost any patient 
Relative safety and relative 
lack of contraindications and 
adverse effects 
Non-opioid analgesic 
Contraindicated in patients with 
severe hepatic impairment 
Nitrous Oxide 
Fast onset and offset 
Adverse effects self-limiting 
due to patient-controlled 
administration 
Non-opioid analgesic 
Bulk of equipment 
Nausea and emesis 
Contraindicated in certain patients 
Methoxyflurane 
Same as nitrous oxide 
Smaller device than nitrous 
oxide 
Not yet available in United States 
Dizziness and headache 
Ketamine 
Fast onset 
Does not cause hypotension 
Minimal effects on respiratory 
drive 
Less potential for abuse than 
opioids 
Non-opioid analgesic 
Numerous adverse effects 
(emergence reactions, hallucinations, 
dizziness, nausea, emesis, sedation, 
hypersalivation, and laryngospasm) 
Schedule III controlled substance 
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SPECIFIC AIMS 
 
This thesis seeks to do the following: 
1. Complete a thorough literature review of the efficacy of non-opioid analgesics as 
compared with common opioid analgesics used in the prehospital setting. 
2. Discuss the findings to answer the following question: Can non-opioid analgesics 
be successfully used as first line treatment for acute pain in the prehospital 
setting? 
This review hopes to provide recommended guidelines for the use of non-opioid 
analgesics as first line treatment for acute pain by EMS providers including guidelines for 
pain management education of EMS providers.  
  
 26 
REPORT OF CURRENT LITERATURE 
 Prehospital emergency care is a relatively new area of healthcare. Within the 
United States, the birth of EMS can be traced to the first published EMS curriculum in 
1969 (Edgerly, 2013). This curriculum was established in response to a report in 1966 
that demonstrated a need for out of hospital medical intervention (National Academy of 
Sciences (US) and National Research Council (US) Committee on Trauma & National 
Academy of Sciences (US) and National Research Council (US) Committee on Shock, 
1966). Since that time, EMS has rapidly grown and evolved. The scope of practice for 
EMS providers has continued to expand and involve more complex treatments and 
interventions. In 2010, EMS became an official medical subspecialty for physicians in the 
United States (M. H. Wilson et al., 2015).  
 Despite the recognition of the importance of EMS, specific research into 
prehospital emergency care is slim. Two common EMS specific journals, Prehospital 
Emergency Care and Prehospital and Disaster Medicine, weren’t established until 1997 
and 1985, respectively. A study searching the Cochrane Library conducted in 2005 found 
that there were only 413 studies performed in the prehospital setting, 63% of which 
pertained to resuscitation and cardiac care (Smith et al., 2007). A lack of prehospital 
research does not mean that the research shouldn’t be performed or isn’t important. In 
fact, the truth is quite contrary. The importance of research in prehospital care appears to 
be universally recognized (Bigham & Welsford, 2015; Cone, 2007; Sayre, White, & 
Brown, 2001; E. Smith et al., 2007; M. H. Wilson et al., 2015).  
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 Like all areas of medicine, research allows for Evidence Based Practice (EBP). 
The National Highway Traffic Safety Administration reported that the lack of EBP was 
an area of concern in the EMS system (Sayre et al., 2001). However, evidence is a 
requirement of increasing the utilization of EBP. One solution is to continue pushing for 
and pursuing prehospital research. This solution, while important, presents significant 
obstacles. The prehospital setting lacks the controlled environment that is important for 
research protocols. There are many different personnel involved in the prehospital setting 
and the study is not conducted in a centralized location. It is also more difficult to acquire 
consent in EMS research. This particular challenge was addressed in one study using a 
two part consent process: initial phone consent with a study physician at the ED and 
formal written consent upon arrival at the hospital (Ducassé et al., 2013). However, the 
EMS units were staffed by nurses who have additional education and training beyond 
typical EMS providers.  
Another option is to consider the translation of EM research into the prehospital 
setting. Depending on the research subject, both options may be valid. The topic of 
applying EM research to EMS is addressed in an article by Drs. Brigham and Welsford. 
While their article emphasizes that careful consideration be made before applying EM 
practices to EMS, they mention that analgesic administration is an appropriate example 
of this practice (Bigham & Welsford, 2015). With this in mind, and due to the relative 
lack of prehospital specific studies pertaining to non-opioid analgesic administration, 
both EMS and EM studies will be considered in this review of the literature. 
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Non-Opioid Analgesic Studies 
 The different non-opioid analgesic studies will be presented in groups according 
to the non-opioid analgesic investigated in the study. The emphasis is on studies that 
compared a non-opioid analgesic with an opioid analgesic. However, a few additional 
studies investigating the efficacy of certain non-opioid analgesics will also be 
highlighted. A summary of certain study characteristics for all the comparison studies can 
be found in Table 3. 
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Table 3. Randomized Trial Characteristics for Studies Comparing Non-Opioid 
Analgesics to Opioid Analgesics. ED – Emergency Department, EMS – Emergency 
Medical Services, y.o. – years old, m.o. – months old 
Non-Opioid Opioid 
Setting 
(ED/ EMS) 
Blinded Source of Pain 
Ages 
Included 
Trial 
Acetaminophen 
Fentanyl ED Yes Renal colic 16-65 y.o. Al et al. 
Morphine 
ED Yes Renal colic 18-55 y.o. Bektas et al. 
ED Yes Renal colic 18-55 y.o. 
Serinken et 
al. 
ED Yes Renal colic 18-65 y.o. Pathan et al. 
ED Yes 
Isolated 
diaphyseal long 
bone fracture 
18-60 y.o. Deloee et al. 
ED Yes 
Isolated limb pain 
caused by trauma 
15-65 y.o. Craig et al. 
ED Yes 
Mechanical low 
back pain 
18-55 y.o. Eken et al. 
Ketorolac Morphine ED Yes 
Isolated limb 
injury (non-
penetrating) 
≥16 y.o. Rainer et al. 
Ibuprofen Morphine 
ED Yes 
Musculoskeletal 
injury 
6-17 y.o. May et al. 
ED Yes 
Uncomplicated 
extremity fracture 
5-17 y.o. Poonai et al. 
Nitrous Oxide Fentanyl ED No 
Isolated extremity 
fracture or 
dislocation 
15-85 y.o. 
Kariman et 
al. 
Ketamine 
Fentanyl ED Yes Extremity injury 8-17 y.o. Frey et al. 
Morphine 
ED Yes Renal colic ≥16 y.o. Farnia et al. 
ED Yes 
Extremity, low 
back, flank, 
abdominal 
18-59 y.o. Miller et al. 
ED Yes 
Musculoskeletal, 
back, flank, 
abdominal 
18-55 y.o. 
Motov et al., 
2015 
ED No 
Mild to moderate 
blunt trauma 
18-70 y.o. 
Shimonovich 
et al. 
EMS No Trauma ≥30 m.o. Tran et al. 
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Acetaminophen 
 There were more studies comparing acetaminophen to the common prehospital 
opioid analgesics than any of the other non-opioid analgesics considered in this literature 
review. Four of those studies investigated pain management in the context of renal colic 
pain (Al et al., 2018; Bektas et al., 2009; Pathan et al., 2016; Serinken et al., 2012). 
Although renal colic is an extremely painful condition that is seen in the prehospital 
setting, those studies did not examine another common cause of pain for patients in the 
prehospital setting. That is, acute pain resulting from trauma. Three studies investigated 
this etiology resulting in pain (Craig, Jeavons, Probert, & Benger, 2012; Deloee, 
Zarmehri, Pishbin, Najafi, & Salehi, 2017; Eken, Serinken, Elicabuk, Uyanik, & Erdal, 
2014).  
 
Al et al., 2018: 
A randomized controlled trial (RCT) investigating acute pain from renal colic 
conducted in Turkey included IV acetaminophen (10 mg) and fentanyl (2 µg/kg) in two 
of the three drug groups (Al et al., 2018). There were a total of 100 patients per drug 
group included in the trial. The VAS was used to assess pain and 93.3% of patients 
reported initial pain between 7 cm and 10 cm with 52% between 9 cm and 10 cm. The 
patients were monitored for 30 minutes, reassessing pain at the 15- and 30-minute mark. 
This study demonstrated that at both the 15- and 30-minute assessments, there was no 
significant difference between the pain relief provided by fentanyl and acetaminophen. 
However, approximately half of the patients in both groups required additional 
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medication at the end of the measured study time. The type of rescue medication used 
was left to provider discretion. It is not mentioned whether the difference in rescue 
medication use between acetaminophen and fentanyl is statistically significant.  
 
Serinken et al., 2012: 
 This RCT compared acetaminophen (1g in 100 mL normal saline) to morphine 
(0.1 mg/kg in 100 mL normal saline) in acute renal colic patients (Serinken et al., 2012). 
After patient exclusions, there were 38 and 35 patients in the acetaminophen and 
morphine groups, respectively (Serinken et al., 2012). Both the VAS and a 4-point VRS 
were assessed at baseline, 15, and 30 minutes.  
Numerically, the results indicated a 7.1 mm difference in mean reduction in VAS 
scores at 30 minutes (Serinken et al., 2012). However, this proved not to be statistically 
significant. As acknowledged by the author, the sample size was not large enough to 
prove equivalence since the study was initially planned as a superiority trial. 15.8% of the 
patients receiving acetaminophen and 20% receiving morphine required rescue 
medication at the end of the trial. The results demonstrated that the acetaminophen group 
experienced fewer adverse events (5.3%) when compared with the morphine group 
(15.3%).  
 
Bektas et al., 2009:  
This randomized, placebo-controlled trial investigating acute renal colic pain 
included three groups: acetaminophen (1 g in 100 mL normal saline; 46 patients), 
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morphine (0.1 mg/kg in 100 mL normal saline), and placebo (100 mL normal saline) 
(Bektas et al., 2009). Pain was assessed at baseline, 15, and 30 minutes using both the 
VAS and the 4-point VRS. The initial mean pain scores were 71 mm for acetaminophen 
and 74 mm for morphine.  
This study reported that fewer patients in the acetaminophen group experienced 
adverse effects (24% vs. 33% in the morphine group); however, statistical significance 
for adverse events was not specifically reported between the two analgesics (Bektas et al., 
2009). The mean reduction in VAS were: 43 mm acetaminophen, 40 mm morphine, and 
27 mm placebo. The authors mention that the results of the 4-point VRS paralleled these 
results. While both medications were effective at reducing pain, there was no difference 
between the analgesics after statistical analysis. Bektas et al. also did not have a large 
enough sample size to prove equivalency, however they did conclude that acetaminophen 
is safe and effective in this patient population. 
 
Pathan et al., 2016: 
The final RCT pertaining to renal colic pain has the largest sample size (Pathan et 
al., 2016). Pathan et al. designed the double-blind, multigroup trial to overcome 
deficiencies of past trials including small sample sizes and a lack of an intention-to-treat 
group. They included 1644 participants in the intention-to-treat group, 1316 of which 
remained in the protocol group after confirmation of ureteric calculi (Pathan et al., 2016). 
The medications investigated are acetaminophen, morphine, and diclofenac. The dosages 
of acetaminophen and morphine are the same as the previous studies: acetaminophen (1 g 
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in 100 mL normal saline) and morphine (0.1 mg/kg in 100 mL normal saline). Pain was 
measured initially (median initial score: 8) and at 30, 60, and 90 minutes post medication 
administration and post-study follow up occurred up to two weeks after the trial. This is 
the only renal colic study that extended the trial beyond 30 minutes. Unlike the previous 
studies, this study used a NRS of 0-10 (Pathan et al., 2016). This beneficial as it is a 
commonly used method for prehospital pain assessment. 
Pathan et al. also took a different approach in defining the primary outcome: 
percentage of patients having a 50% reduction in their pain score at 30 minutes. The 
results of this study showed statistical significance between acetaminophen and morphine 
(Pathan et al., 2016). At 30 minutes, 68% of patients in the acetaminophen group 
achieved the primary outcome compared with 60% in the morphine group (Pathan et al., 
2016). As a secondary outcome, 83% of patients in the acetaminophen group had 
achieved at least a 3-point reduction in NRS scores at 30 minutes compared with 78% in 
the morphine group. 23% of the acetaminophen group patients required rescue analgesia 
(25% for morphine). Finally, the acetaminophen group experienced fewer acute adverse 
events compared to the morphine group (1% vs. 4%). The authors did note that the low 
adverse event rates for the morphine group may have been due to the patient population 
of the study. 
 
Deloee et al., 2017: 
The first of three small studies investigating pain related to trauma compared IV 
acetaminophen to IV morphine in patients presenting to the ED with isolated diaphyseal 
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long bone fractures (Deloee et al., 2017). The initial mean VAS score was 90 mm, which 
was assessed after non-pharmacologic pain management had been provided. After 
allocation, 26 patients received 0.1 mg/kg morphine and 24 patients received 15 mg/kg of 
acetaminophen. This was the only acetaminophen study that utilized a weight-based 
dosage for the acetaminophen group. Both upper extremity and lower extremity fractures 
were distributed between both groups without a statistically significant difference 
between groups (Deloee et al., 2017). Using the VAS assessment at 0, 5, and 30 minutes, 
Deloee et al. only found a statistically significant difference in pain score at the 5-minute 
mark (mean difference of 14.57 favoring morphine); neither medication was superior to 
the other at 30 minutes. In addition to the small sample size, this study also didn’t report 
adverse effects or the need for rescue analgesia. 
 
Craig et al., 2012: 
A RCT conducted in the U.K. also compared IV acetaminophen (27 patients at 1 
g) and IV morphine (28 patients at 10 mg), but in the context of isolated acute limb pain 
caused by trauma (Craig et al., 2012). To be included in the study, patients had to report 
an initial NRS of at least 7/10. One main difference in this study is that the medications 
were infused over a longer time period (15 minutes). The VAS was used to assess pain at 
0, 5, 15, 30, 45, and 60 minutes. No significant difference between the two medications 
was shown at any point throughout the trial. However, the morphine group had 
significantly more adverse reactions (8 patients vs. 2 for acetaminophen). In addition, one 
of the secondary outcome measures was patient satisfaction. This was an important 
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measure to include given the subjective nature of the pain experience for patients. 
However, the results on patient satisfaction did not reach statistical significance (Craig et 
al., 2012).  
 
Eken et al., 2014: 
The final acetaminophen study included dexketoprofen in addition to 
acetaminophen (1 g in 100 mL of normal saline) and morphine (0.1 mg/kg in 100 mL of 
normal saline) (Eken et al., 2014). Pain was assessed initially and at 15 and 30 minutes 
after analgesic administration using both the VAS and 4-point VRS. To be included in 
the study, patients must report moderate or severe pain on the initial 4-point VRS. There 
were a total of 46 patients in the acetaminophen group and 45 in the morphine group. 
Though still a relatively small study, it is the largest study found comparing 
acetaminophen to a common prehospital opioid for traumatic pain. Specifically, acute 
mechanical low back pain was investigated in this study (Eken et al., 2014). The results 
showed consistency between the VAS and 4-point VRS scores. Although the study did 
not reach significance in terms of rescue analgesic administration and adverse events, it 
did demonstrate that morphine was not superior to acetaminophen at the end of the trial. 
However, the reduction of the mean VAS score for morphine was 11 mm greater than the 
score for the acetaminophen group at 15 minutes (statistical significance not stated). The 
clinical significance of this difference will be addressed in the discussion section.  
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Ketorolac 
 There were numerous RCTs investigating the use of ketorolac for analgesia in 
other settings and comparing ketorolac with certain opioid and non-opioid analgesics. 
However, there were a lack of RCTs that compared ketorolac to one of the common 
prehospital opioid analgesics in the EMS or ED settings (excluding studies investigating 
surgical procedures). There were no prehospital RCTs and only one ED based RCT 
(Motov, Yasavolian, et al., 2017; Rainer et al., 2000). In addition to that study, one other 
RCT will be presented as it demonstrates the efficacy of ketorolac in the ED (Motov, 
Yasavolian, et al., 2017).  
 
Motov, Yasavolian, et al., 2017: 
This study investigated the efficacy of IV ketorolac at three difference doses 
(Motov, Yasavolian, et al., 2017). The patients were included if their chief complaint at 
the ED was acute pain with a score of 5 or greater on the NRS. 80 patients were included 
in each of the three dosage groups (10 mg, 15 mg, and 30 mg). Pain scores were recorded 
at 15, 30, 60, 90, and 120 minutes in addition to baseline pain scores prior to analgesic 
administration. The primary outcome was a reduction in pain scores at 30 minutes. The 
patients in the 10 mg group went from a mean NRS score of 7.7 to 5.2 at 30 minutes, 
which was statistically significant. Of note, there was not a significant difference in the 
analgesic efficacy between the three doses studied. 
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Rainer et al., 2000: 
 A double blind RCT in Hong Kong compared IV ketorolac with IV morphine in 
patients presenting to the ED with isolated limb injury (Rainer et al., 2000). The primary 
goal was a cost analysis of the two analgesics. The secondary outcomes were pain relief 
(both at rest and with movement), adverse events, time spent in the ED, and patient 
satisfaction. Pain scores were assessed using a VAS at baseline and then at various 
timepoints up until one and a half hours followed by one final assessment at six hours. 
The median initial pain was approximately 4/10 at rest and 8/10 with movement. Pain 
relief was reported as a likelihood of reaching 50%, 75%, and 100% pain reduction 
(100% was not recorded for the with movement assessment) and as a rate of pain 
decrease per hour.  
 A total of 149 patients were divided between the two study groups: 75 for 
ketorolac and 74 for morphine (Rainer et al., 2000). Ketorolac was given with an initial 
10 mg dose followed by additional 5 mg doses every 5 minutes with a maximum of 30 
mg. Morphine was given as 5 mg initially followed by 2.5 mg every 5 minutes up to 15 
mg total. Medication administration would cease if there was complete resolution of pain 
at rest.  
 The clinical results of the study showed that the morphine group was 16 times 
more likely to experience adverse effects compared with ketorolac (Rainer et al., 2000). 
In fact, three patients were admitted to the hospital from the morphine group due to 
adverse events (none from the ketorolac group). In both measures of pain relief at rest, 
morphine was not superior to ketorolac. With activity, the likelihood of a 50% reduction 
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in pain was not statistically significant between the two groups. However, ketorolac was 
shown to be more likely to achieve a 75% reduction in pain with movement compared to 
morphine. In addition, the per hour rate of decrease in pain score was greater with 
ketorolac. Patients in the ketorolac group were also more satisfied with their pain 
management.    
 This study is also useful as it provides a cost analysis between morphine and the 
more expensive ketorolac (three times more expensive at the time of the study) (Rainer et 
al., 2000). When admissions costs were taken into consideration there was no significant 
difference in total costs between ketorolac and morphine. Ketorolac becomes the cheaper 
medication to administer when the analysis is done for the cost to only the ED and 
pharmacy. Morphine, due to adverse events, also increases the time that nursing and 
physician staff takes managing each patient given that medication. Finally, patients in the 
ketorolac group were discharged from the ED significantly sooner than patients in the 
morphine group. The study by Rainer et al. was the only study found that performed a 
cost analysis of a non-opioid vs. opioid analgesic.   
 
Ibuprofen 
 Similar to ketorolac, ibuprofen is also an NSAID. No RCTs were found that 
compared ibuprofen with a parenteral administration of morphine or fentanyl in an 
appropriate context for EMS. There were two studies that compared a PO administration 
of ibuprofen with PO morphine (May et al., 2017; Poonai et al., 2014). These two studies 
exclusively investigated the pediatric population. Although they will be presented, the 
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significant limitations in applying the findings to EMS will be discussed in the 
Limitations in Reported Literature section.  
 
Poonai et al., 2014: 
 The first study compared the analgesic efficacy of normal release PO morphine 
(0.5 kg/mg, max of 10 mg) to PO ibuprofen (10 mg/kg, max of 600 mg) in patients being 
discharged from the ED after a confirmed extremity fracture (Poonai et al., 2014). The 
study was conducted by patients and their guardians after discharge from the ED using 
instructions and survey forms. A revised faces style scale, which gave each face a value 
from 0 – 5, was used to assess pain severity before and 30 minutes after each dose was 
given. A maximum of four doses of the study medication were available, with 
instructions to take every six hours as needed and to use acetaminophen as a rescue 
analgesic if needed.  
 The primary outcome of the study was the difference in pain score measured after 
the first dose was given (Poonai et al., 2014). There were 66 participants in the morphine 
group and 68 in the ibuprofen group all 5-17 years old. The median pain score recorded 
at discharge was 2; however, only the differences in pain scores were reported for the 
self-administered doses after discharge. While both medications resulted in a clinically 
significant decrease in pain, there were no significant differences reported between 
groups. The study also reported no significant difference in rescue analgesia use and 
significantly more adverse effects in the morphine groups. It is mentioned that the study 
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was not adequately powered to detect between group differences in these secondary 
outcome measures. 
 
May et al., 2017: 
 The second study compared the analgesic efficacy of PO morphine (0.2 mg/kg, 
max of 15 mg), PO ibuprofen (10 mg/kg, max of 600 mg), and a PO combination of both 
morphine and ibuprofen combined at the same dose as the individual groups in patients 
presenting to the ED with a musculoskeletal injury to one limb (May et al., 2017). The 
entire study was conducted in the ED and utilized the 100 mm VAS scale for pain 
assessment at baseline and 30, 60, 90, and 120 minutes after analgesic administration. 
Participants were 6-17 years old. There were 201 patients each in the two groups 
containing morphine and 99 patients in the ibuprofen group.  
 The participants had an approximate initial mean VAS of 61 mm in all groups 
(May et al., 2017). The primary outcome for each group was the number of participants 
achieving a VAS less than 30 mm at the 60-minute assessment. At 60 minutes, there was 
no significant difference between groups in the percentage of patients achieving the 
primary outcome (33% for ibuprofen, 29% for morphine, and 30% for the combination 
group). May et al. also reported no significant difference between groups after separating 
each group into two groups based on initial pain severity (a 30 mm – 69 mm group and a 
group with at least 70 mm).  
This RCT also reported the mean VAS decrease, rescue analgesic use, and 
adverse effects (May et al., 2017). The 120-minute assessment was the only timepoint 
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that reported a significant difference in the mean VAS decrease between the morphine 
group (-16.5 mm) and ibuprofen group (-27.1 mm), not the combination group. That is a 
10.6 mm difference between those groups. Both the combination group and the morphine 
group had significantly more adverse effects compared to the ibuprofen group (21.5%, 
20.7%, and 6.6%, respectively) (May et al., 2017). Only five patients in total required 
rescue analgesia, and the significance of the difference between groups was not reported. 
 
Nitrous Oxide 
 Nitrous oxide is the first of two inhalation analgesics that will be discussed. It is 
typically administered as a mixture with oxygen. All of the studies being considered 
utilized a mixture of 50% nitrous oxide and 50% oxygen (Ducassé et al., 2013; Kariman 
et al., 2011; Triner, Bartfield, Birdwell, & Raccio-Robak, 1999). For simplicity, the 
mixture will be referred to as “nitrous oxide” going forward. Only one of the three studies 
compared nitrous oxide with an opioid analgesic (Kariman et al., 2011). However, the 
other two efficacy studies, comparing to placebo, demonstrate notable results (Ducassé et 
al., 2013; Triner et al., 1999). 
 
Triner et al., 1999: 
 A small double-blind, randomized, pilot study compared nitrous oxide to 100% 
oxygen in patients diagnosed with a migraine history presenting to the ED with an acute 
migraine (Triner et al., 1999). Although this study did not compare nitrous oxide with a 
common prehospital analgesic, it is useful to consider given the results on the efficacy of 
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nitrous oxide on acute pain in the ED. The 100 mm VAS was used to assess pain prior to 
treatment and after treatment was discontinued (Triner et al., 1999). Patients had access 
to the treatment, which was supplied via a demand valve device, for 20 minutes, however 
they were not required to use the gas continuously. Patients were monitored for an 
additional 20 minutes to record the use of additional analgesics agents after discontinuing 
the study treatment.  
 There were 10 patients in the nitrous oxide group and 12 in the oxygen group with 
no significant difference in initial median VAS scores (69 mm for nitrous oxide group 
and 78.5 mm for oxygen group) or other baseline characteristics (Triner et al., 1999). The 
oxygen group did not have a significant reduction in pain scores at the end of treatment. 
The median score decreased to 21 mm in the patients receiving nitrous oxide. Only 20% 
of patients receiving nitrous oxide required rescue analgesics at the end of treatment 
(84% for oxygen group). 20 minutes after nitrous oxide was discontinued, 60% of 
patients in that group still did not require rescue analgesics and were discharged having 
only been treated with nitrous oxide. The study was not large enough to report on adverse 
events and did not follow up with patients after the 40-minute period.  
 
Kariman et al., 2011: 
 The next study investigated if nitrous oxide was superior to a single dose of 
fentanyl in patients presenting to the ED with an isolated extremity fracture or dislocation 
confirmed by X-ray (Kariman et al., 2011). Patients were required to have a VAS score 
of at least 4 out of 10 to be included in the trial. Unlike the previous study, this study was 
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not blinded. The authors cite the difficulty of blinding considering the equipment 
required to administer nitrous oxide. Pain was recorded prior to treatment and at 3, 6, 9, 
and 60 minutes after treatment began, although additional analgesics were allowed prior 
to 60 minutes.  
There were 50 patients in each group (Kariman et al., 2011). Patients in the 
nitrous oxide group self-administered the treatment for a maximum of 15 minutes or until 
their pain was controlled. Patients in the fentanyl group received 6 L/min of oxygen and 
fentanyl at 2 µg/kg with no maximum dose limit. There was no significance between the 
two groups at 3, 6, and 60 minutes. However, the nitrous oxide group had a statistically 
significant difference in the VAS assessment at 9 minutes (2.2 vs. 3.1 for fentanyl). The 
authors caution that the clinical significance of that is unclear. 
 
Ducassé et al., 2013: 
While the final study only assessed the efficacy of nitrous oxide compared to 
medical air (MA) rather than to an opioid analgesic, it did so in the prehospital setting in 
France (Ducassé et al., 2013). Nitrous oxide is also currently in the state protocols of at 
least three states in the United States: Alabama, New Hampshire, and Vermont (Alabama 
Department of Public Health Office of Emergency Medical Services, 2018; New 
Hampshire Department of Safety Division of Fire Standards and Training and Emergency 
Medical Services, 2018; Vermont Department of Health Office of Public Health 
Preparedness and Emergency Medical Services, 2018). The EMS system where the study 
took place includes ambulances staffed by nurses (Ducassé et al., 2013). These nurses, in 
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conjunction with a physician at the ED, enrolled and treated qualifying patients according 
to the study protocol. This study included any patient with acute traumatic pain with a 
NRS score between 4 and 6 out of 10. Each treatment group included 30 patients. 
Patients were treated in their randomly assigned group for 15 minutes (Ducassé et 
al., 2013). After 15 minutes, all patients were treated with nitrous oxide until arrival at 
the hospital. Assessments were conducted initially and on five-minute intervals for 30 
minutes. If they had not reached the hospital at 30 minutes, assessments continued every 
15 minutes until arrival. Once at the hospital, patients and nurses were asked to report 
their satisfaction with analgesia. Keep in mind, both groups would have received nitrous 
oxide treatment at that point.  
Analgesic efficacy results were reported as a percentage of patients with an NRS 
score of 3 or below after 15 minutes of treatment (Ducassé et al., 2013). They also 
reported median pain scores. After 15 minutes of treatment, 67% of the nitrous oxide 
group achieved the efficacy goal compared to 27% of the MA group. The nitrous oxide 
group also reported a lower median NRS score at 15 minutes (2 vs. 5 for MA), which was 
statistically significant starting on the first assessment at 5 minutes. Ducassé et al. 
reported no significant difference in the baseline characteristics between the two study 
groups. In addition, at 20 minutes (5 minutes after all patients received nitrous oxide 
treatment) there was no longer a significant difference between the two groups.  
While most studies reported pain relief, this was one of the few studies to record 
patient and provider satisfaction with treatment. Upon arrival at the ED, with all patients 
having received nitrous oxide treatment, all but one of the 60 patients involved in the 
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study reported being either satisfied or very satisfied with the analgesic treatment 
(Ducassé et al., 2013). Similarly, all but two of the prehospital nurses involved in the 
study were equally as satisfied as the patients.       
 
Methoxyflurane 
 The second inhalation analgesic is methoxyflurane. It has been used as an 
analgesic to treat acute pain for over 40 years in Australia and is approved for use in 
many other countries (Porter et al., 2018). Despite the length of time it has been in use, 
there are few completed RCTs demonstrating its efficacy. The STOP! study is a double-
blind RCT that was conducted in the UK and compared methoxyflurane to placebo in 
patients presenting to the ED with acute pain from minor trauma (Frank Coffey et al., 
2014). To be included, the initial NRS score was required to be between 4 and 7. A total 
of 149 patients were included for analysis in each group (approximately 40% between the 
ages of 12 and 18). The primary outcome was the change in VAS score at 5, 10, 15, and 
20 minutes after treatment began.  
 Patients in the methoxyflurane group received one inhaler device (3 mL) to self-
administer the medication at the start of treatment (Frank Coffey et al., 2014). The 
placebo group received the same inhaler device filled with 5 mL of a saline placebo. Both 
groups were given the option of receiving a second inhaler or rescue medication at any 
time throughout the study if the patient requested it.  
The study demonstrated that the change in VAS score was significantly greater 
for the methoxyflurane group compared to placebo at all time points (Frank Coffey et al., 
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2014). The greatest change was seen at 15 minutes with a decrease of 18.5 mm from 
initial pain score. It took four minutes (median value) for patients receiving 
methoxyflurane to report initial pain relief. In total, 87.2% of patients in the 
methoxyflurane group had pain relief and only 1.3% requested rescue analgesia. 
Two follow up sub-group analysis abstracts reported on the efficacy of 
methoxyflurane for patients reporting a NRS of 7 (severe pain) initially (Coffey, Mirza, 
& Lomax, 2018a, 2018b). These results demonstrated that in the severe pain sub-group, 
methoxyflurane still had a significantly shorter time to initial pain relief (Coffey et al., 
2018b). Finally, the percentage of patients experiencing at least a 30% decrease in pain 
was significantly higher in the methoxyflurane group compared to placebo up to 90 
minutes after treatment began (Coffey et al., 2018a). Although methoxyflurane is 
available in other countries across the world, the United States does not currently have 
access to this medication. A report by a company that sells the methoxyflurane delivery 
device indicates that United States approval is currently in progress (Wilson, 2019).    
 
Ketamine 
 Ketamine is more well known as an anesthetic agent at higher doses. Its use as an 
analgesic at lower, sub-dissociative, doses is also understood and becoming more 
common. As an example, as of January 1st, 2018, New Hampshire has added low dose 
ketamine for analgesia to their statewide EMS protocols (New Hampshire Department of 
Safety Division of Fire Standards and Training and Emergency Medical Services, 2018). 
Six RCTs compared ketamine to morphine or fentanyl in the setting of acute pain (Farnia 
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et al., 2017; Frey et al., 2019; Miller, Schauer, Ganem, & Bebarta, 2015; Motov et al., 
2015; Shimonovich et al., 2016; Tran et al., 2014). These studies varied in the etiology 
resulting in pain and the routes of administration for the analgesics. Only one study 
exclusively investigated the pediatric population (Frey et al., 2019). 
 
 Farnia et al., 2017: 
 The first RCT investigated IN ketamine (1 mg/kg; 20 patients) and IV morphine 
(0.1 mg/kg; 20 patients) in patients at least 16 years old presenting to the ED with renal 
colic pain (Farnia et al., 2017). In addition, the study utilized a placebo morphine and 
ketamine so that each patient received both an IN and an IV administration. Fentanyl was 
offered as a rescue analgesic after 30 minutes. The VAS was used to assess pain prior to 
and 5, 10, 15, and 30 minutes after medication administration. Although the VAS is 
reported in other studies in millimeters, this study reported the VAS score on a scale of 
0.00-10.00. This likely translates to a centimeter representation of the scale, however this 
was not stated in the study.  
 The mean initial pain score was statistically significant between the ketamine and 
morphine groups (8.35 and 7.4, respectively) (Farnia et al., 2017). This study took this 
difference in baseline score into account during analysis. There was no significant 
difference reported between the study groups at 15 and 30 minutes. However, the 
difference between mean scores at 5 minutes favored morphine, but only marginally 
(0.79 mean difference). The clinical significance of this will be addressed in the 
discussion. The study showed no significant difference in rescue analgesia use (Farnia et 
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al., 2017). Eight patients in the morphine group experienced hypotension and six patients 
in the ketamine group experienced an emergence reaction. 
 
Tran et al., 2014: 
 This RCT did not utilize a blinded protocol and was carried out in a rural, low-
resource, prehospital setting (Tran et al., 2014). The study included any patient over 2.5 
years old that was in need of analgesia after a trauma (Tran et al., 2014). There were 308 
participants included in the analysis. The study participants had many notable 
characteristics: 24 patients under 15 years old, 28 patients with multiple injuries 
considered major, 91% of patients suffered a blunt trauma, 61% of injuries were from a 
road accident, and 24% were from falls. The study excluded patients with transport times 
less than 10 minutes and had a mean prehospital treatment time of 2.2 hours.  
The study was conducted by physicians who responded into the field and 
transported the patient either by ambulance or taxi (Tran et al., 2014). The two 
medication groups were IV ketamine (169 patients at 0.2-0.3 mg/kg) and IM morphine 
(139 patients at 10 mg for adults and 5 mg for children). The initial pain severity was not 
reported. The VAS was used to assess pain. Unlike other studies, the physician rated the 
patient’s pain instead of the patient. The study concluded that both analgesics were 
equally effective in reducing pain severity and that transport time and the severity of the 
initial injury did not affect the efficacy. Nausea and vomiting were significantly more 
often reported in the morphine group (19% of patients) than the ketamine group (5% of 
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patients). The proportion of patients experiencing agitation was reported as statistically 
significant between the two groups (11% for ketamine and 1.5% for morphine). 
 
Shimonovich et al., 2016: 
The second unblinded study compared IN ketamine (24 patients at 1 mg/kg) to IM 
morphine (27 patients at 0.15 mg/kg) and IV morphine (24 patients at 0.1 mg/kg) in adult 
patients presenting to the ED with acute pain after a mild to moderate blunt trauma 
(Shimonovich et al., 2016). The VAS was used to assess initial pain and every five 
minutes for the first hour after medication administration. To be included in the study, 
participants had to have an initial pain score of at least 80 mm. The initial mean pain 
score was approximately 91 mm for all groups.  
The study included several outcome measures: time to achieve a 15 mm VAS 
decrease, time to reach and extent of maximum pain reduction, adverse effects, and 
patient satisfaction (Shimonovich et al., 2016). There was no significant difference found 
in the time to reach or extent of maximum pain reduction of the IM or IV morphine 
groups compared to the IN ketamine group. The difference in time to onset and rate of 
reduction in pain scores of IN ketamine and IV morphine were also found not to be 
statistically significant. IN ketamine did have a significantly shorter time to onset: 14.3 
minutes versus 26 minutes for IM morphine. IM morphine was also shown to have a 
slower rate of pain score reduction than either of the other medication groups. The 
satisfaction rating, as measured by patients marking a position on a VAS line, was not 
found to be statistically significant between the groups.  
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The adverse effects were categorized as difficulty concentrating, dizziness, 
confusion, and dry mouth (Shimonovich et al., 2016). These categories were reported as 
the percentage of patients experiencing each adverse effect. Ketamine was statistically 
significant compared to the two morphine groups in both the difficulty concentrating 
(58.3% for ketamine, 20.8% for IV morphine, and 22.2% for IM morphine) and the dry 
mouth (25% ketamine, 79.2% IV morphine, and 63% IM morphine) categories. More 
patients in the IN ketamine group experienced dizziness compared to the IM morphine 
group (79.2% and 22.2%, respectively) with no statistical difference between IN 
ketamine and IV morphine. The IN ketamine group experienced more confusion than the 
IV morphine group (50% and 12.5%, respectively). 
 
Frey et al., 2019:  
This study also investigated IN ketamine, but compared it to IN fentanyl (Frey et 
al., 2019). This RCT investigated patients with an extremity injury, was double-blinded, 
and utilized a non-inferiority trial. Only pediatric patients with a VAS pain score greater 
than 35 mm were included in the study (8-17 years old). Opioid analgesic use prior to 
arrival at the ED excluded patients; however, non-opioid use prior to arrival was allowed. 
The IN ketamine group (1.5 mg/kg, max of 100 mg) analyzed 43 patients and the IN 
fentanyl group (2 µg/kg, max of 100 µg) analyzed 42 patients.  
The VAS was used to assess pain at baseline and 15, 30, and 60 minutes after 
analgesic administration (Frey et al., 2019). The mean of the two initial pain scores for 
both groups was 73.4 mm. The primary outcome measure, the difference in mean 
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decrease in pain score from baseline, was assessed at 30 minutes. The study demonstrated 
that IN ketamine is non-inferior to IN fentanyl. There were also no significant differences 
in the lowest pain score, vital signs, or sedation scores between groups. Adverse effects 
were reported as minor and transient with the only significant difference between groups 
noted at the 15-minute assessment. Overall, 77% of ketamine patients and 31% of 
fentanyl patients reported adverse effects. Finally, there was no significant difference in 
the use of rescue analgesia, with 23% of all patients requiring a rescue analgesic. 
 
Miller et al., 2015: 
IV ketamine (0.3 mg/kg) was compared to IV morphine (0.1 mg/kg) in this 
double-blind RCT conducted in the ED with adult patients (J. P. Miller, Schauer, Ganem, 
& Bebarta, 2015). The medications were administered over 5 minutes. The study 
investigated patients presenting to the ED with acute abdominal, flank, low back, or 
extremity pain from any etiology. Patients were included in the study if the physician felt 
that opioid analgesics were warranted and if opioids or tramadol had not been used in the 
past four hours. The NRS was utilized for pain assessment. There were 24 patients 
analyzed in the IV ketamine group (maximum dose of 25 mg allowed) and 21 patients 
analyzed in the IV morphine group (maximum dose of 8 mg allowed). Patients were 
allowed a second dose at their request as early as 20 minutes; however, requesting a third 
dose resulted in the termination of data collection for that patient. Repeat dosing in this 
study was used instead of a separate rescue analgesic. In addition, midazolam and 
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naloxone were available to providers for adverse effects if needed. However, no patient 
received those medications throughout the course of the study.  
The initial mean pain severity in both treatment groups was 7.1 out of 10 on the 
NRS (Miller et al., 2015). Pain was also assessed at 5, 10, and 20 minutes, and then every 
20 minutes for 2 hours with time starting after the infusion had finished. The maximum 
change in NRS score was achieved significantly earlier for ketamine (4.9-point reduction 
from baseline at 5 minutes) compared to morphine (5-point reduction from baseline at 
100 minutes). It was noted that despite its fast onset, ketamine did not sustain its 
analgesic effect as well as morphine. The mean pain score reduction achieved at least a 
50% reduction from baseline at all timepoints after 20 minutes. No significant difference 
was observed in the proportion of patients requiring additional doses between the groups. 
It is important to note that patients in both the ketamine and morphine group required a 
third dose (25% and 14%, respectively).  
The number of adverse events reported was also not statistically significant 
between groups (Miller et al., 2015). Hallucinations and dysphoria were only noted in the 
ketamine group and headache and drowsiness were only noted in the morphine group. 
There was no difference reported in the sedation and agitation scale used by the study. 
This study also assessed physician and nurse satisfaction. While the nurse satisfaction 
was slightly higher in the ketamine group, it was reported as not clinically significant. No 
other differences in satisfaction were observed.  
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Motov et al., 2015: 
The final ketamine study investigated patients complaining of acute abdominal, 
flank, back, and musculoskeletal pain with an initial pain score of at least 5 out of 10 on 
the NRS (Motov et al., 2015). Patients were excluded if opioids were used in the past 
four hours. The two groups were IV ketamine (0.3 mg/kg; 45 patients) and IV morphine 
(0.1 mg/kg; 45 patients). The medication was administered over 3-5 minutes. Rescue 
fentanyl was available for patients if needed at 30 and 60 minutes. Pain was assessed 
using the NRS every half an hour for two hours and at 15 minutes.  
The initial mean pain score for both groups was approximately 8.5 on the NRS 
(Motov et al., 2015). There was no difference noted in the mean reduction of pain scores 
between groups at the 15- and 30-minute assessments. Interestingly, at 15 minutes, more 
patients in the ketamine group reported complete resolution in pain compared to the 
morphine group (31% difference between groups). This difference was no longer present 
by 30 minutes. None of the complete resolution of pain patients used rescue analgesia. 
There was no significant difference noted in the proportion of patients achieving at least a 
3-point reduction in pain score. There was a 38% difference in the proportion of patients 
experiencing adverse effects, more in ketamine group, immediately and at 15 minutes 
after medication administration. The difference was no longer noted at the 30-minute 
assessment. Although ketamine is a non-opioid analgesic, it is still considered a 
controlled substance with abuse potential. As such, these results will be discussed 
separately from the other non-opioid analgesics. 
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Non-Opioid Analgesics as First Line Treatment 
 After evaluating the efficacy of non-opioid analgesics on pain relief and patient 
satisfaction, it is important to consider the application aspect of non-opioid analgesics as 
first line treatment. The Maimonides Medical Center in Brooklyn, New York, underwent 
a study that ran for eight hours to investigate the application of a non-opioid first protocol 
(Cohen et al., 2015). They took an approach termed channel enzyme receptor-targeted 
analgesia to develop their non-opioid first protocol. This protocol outlined what non-
opioid medications should be used based on pain severity (NRS from 0-10) and 
underlying cause. Notably, the protocol utilized more types of analgesics than are used in 
EMS. 
 Every patient seen in the ED over the course of one eight hour shift, with a chief 
complaint of pain, was treated using the study protocol (Cohen et al., 2015). Pain was 
recorded prior to analgesic administration and at 30 and 60 minutes after administration. 
A rescue dose of opioid analgesics was available only after 30 minutes. In addition to 
pain assessment, adverse events, and whether patients were satisfied were also recorded.  
 Of the 17 patients treated during the study, 12 of them had acute pain (Cohen et 
al., 2015). The median NRS pain score for all patients prior to analgesic administration 
was 8. 41% of patients reported at least a 30% reduction in pain by 30 minutes. Only one 
patient received rescue analgesia. In the acute pain group, 83% of patients were satisfied 
with their pain relief at 30 minutes. IV ketorolac, IV acetaminophen, and oral ibuprofen 
were the three most common analgesics used during the study.  
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 More recently, a level 1 trauma, burn, and stroke center in Colorado investigated 
the application of a non-opioid first protocol over a three month period (Duncan, Smith, 
Maguire, & Stader, 2019). The protocol gave first-line treatment, second-line treatment, 
and alternative options based on the cause of the pain. The protocol also utilized more 
analgesics than are available to EMS. This study looked at the percentage of patients 
receiving opioid and non-opioid analgesics before and after implementing the protocol 
(Duncan et al., 2019). In addition, patient satisfaction was recorded using the Press 
Ganey survey. 
Almost 30,000 patients were analyzed in both the pre- and post-implementation 
periods (Duncan et al., 2019). After the protocol was implemented there was a 20% 
reduction in IV opioid administration. IV acetaminophen had a 29.5% increase in use and 
IV ketorolac had a 73.7% increase. The study found that there was no significant 
difference in patient satisfaction before or after the implementation of the study protocol.  
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EVALUATION OF CURRENT LITERATURE 
Limitations in Reported Literature 
The strength of evidence is an important consideration when discussing an 
alternative treatment to the standard of opioid analgesics. With two exceptions, only 
RCTs were used as the main source of evidence as they represent a rigorous study design 
and provide the strongest initial evidence (Guyatt et al., 2011). The two exceptions were 
two studies that reported on non-opioid first protocols in practice in the ED and will be 
discussed separately. However, there are several reasons why the level of evidence from 
an RCT may be weaker than initially assumed or why strong evidence may not lead to a 
strong conclusion. One concern is the ability to generalize the study results to the EMS 
population in question. One aspect of generalization is having a representative research 
population. The similarities in patient population between EM and EMS have been 
previously discussed. Although careful consideration should be made, research in 
analgesic administration in EM can be successfully applied to EMS (Bigham & 
Welsford, 2015). This section will address the significant limitations in the reported 
RCTs. 
 
Non-Opioid Studies, Excluding Ketamine: 
 There are six publications that did not include an opioid analgesic as a 
comparison group (Coffey et al., 2018a, 2018b; Coffey et al., 2014; Ducassé et al., 2013; 
Motov, Yasavolian, et al., 2017; Triner et al., 1999). The three publications by Coffey et 
al. were the only studies reported that investigated methoxyflurane (Coffey et al., 2018a, 
 57 
2018b; Coffey et al., 2014). Since they cannot be utilized in isolation to compare non-
opioid analgesics to opioid analgesics and because they are the only studies investigating 
methoxyflurane, those three studies will not be considered as evidence in the non-opioid 
group. The other three studies investigated the same non-opioid analgesic utilized in 
other comparison studies (Ducassé et al., 2013; Motov, Yasavolian, et al., 2017; Triner et 
al., 1999). However, one study exclusively investigated migraine headache (Triner et al., 
1999). This study is excluded from the review as the etiology resulting in pain is not 
represented in the comparison studies. The other two studies can be used as additional 
supporting evidence in conjunction with the other comparative studies.  
 The only two studies investigating ibuprofen utilized PO morphine as the 
comparison group (May et al., 2017; Poonai et al., 2014). PO morphine is not commonly 
utilized by EMS. In addition, the PO route is subject to the first pass effect, which causes 
only a portion of the administered medication to reach systemic circulation. Without an 
additional study comparing to IV or IM morphine, which are commonly used in EMS, the 
ability to generalize these results to EMS is significantly limited. As such, Ibuprofen will 
not be considered in the conclusions. 
 In the remaining comparison RCTs, there is one significant dose discrepancy that 
should be noted. One study investigating acute pain from renal colic administered a 10 
mg dose to the acetaminophen group (Al et al., 2018). This dose is significantly lower 
than the 600 mg – 1000 mg typically administered by EMS. Results in this study favoring 
fentanyl may have been skewed by the low dose in the acetaminophen group. In isolation, 
the results of this study present weaker evidence when generalizing to EMS due to this 
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disparity between the doses. This study will be included as evidence since there are three 
other studies with an acetaminophen group investigating renal colic that administered a 
dose typical of EMS. 
The age of the patients included in the remaining nine comparison RCTs is 
another limiting factor to generalizability. Only two studies had a minimum age of 15 
years old, but they also included adult patients in the study (Craig et al., 2012; Kariman et 
al., 2011). These studies only provide limited evidence for patients who are 15 years old. 
Due to these age limitations, the conclusions in this review should only be utilized for 
patients who are at least 16 years old. 
There are also several limitations to the different etiologies resulting in pain that 
are included in the remaining comparison studies. Multisystem trauma patients and 
patients in extremis are not well represented in the reported literature. In addition, several 
RCTs specified that the study was investigating isolated limb trauma. The only non-
traumatic etiology resulting in pain was renal colic. The narrow scope of patients 
included in these trials prevents a general statement regarding the use of non-opioid 
analgesics as first line treatment by EMS. More specific conclusions will be made in the 
remaining sections of the review.  
 
Ketamine Studies: 
 Three of the ketamine studies contained significant limitations (Farnia et al., 
2017; Frey et al., 2019; Tran et al., 2014). However, none of the limitations resulted in 
the study being completely excluded from use as evidence. There was only one study that 
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investigated ketamine and an opioid, morphine, in patients presenting to the ED with 
acute pain specifically from renal colic (Farnia et al., 2017). Due to the small sample size 
of this study, 20 patients per group, this study does not present enough evidence to 
support a specific recommendation for ketamine regarding pain from renal colic. This 
study will be used in combination with the other ketamine studies to make a more general 
recommendation. 
The EMS study has a severe limitation that prevents it from being used as 
evidence in the effect on pain severity outcome measure. In this study, the physicians 
reported their observed pain severity instead of having the patients report their level of 
pain (Tran et al., 2014). The importance of patient reported assessments in pain 
management is why this study will not be utilized to compare the analgesic efficacy of 
ketamine to the opioid analgesics. 
The final study with a significant limitation is the only ketamine study to 
exclusively investigate the pediatric population. The study investigated extremity injuries 
in patients 8-17 years old and utilized a non-inferiority design (Frey et al., 2019). This 
study presents significant evidence, despite being the single study investigating pediatric 
patients, because of the strength of the non-inferiority design. The limitation of this study 
comes from the narrow etiologies included. Only a specific recommendation for pediatric 
patients experiencing pain from an extremity injury can be made from this study.  
Similar to the other non-opioid studies, multisystem trauma patients and patients 
in extremis are not well represented in the ketamine studies. Except for the separate 
recommendations resulting from the pediatric study, the recommendations from the 
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remaining five ketamine studies should only be utilized for patients who are at least 18 
years old. As such, a general statement regarding ketamine use by EMS cannot be made. 
As was the case with the other non-opioid studies, more specific conclusions regarding 
ketamine will be made in the remaining sections of this review.  
 
Non-Opioid First Studies: 
 There were three significant limitations in the studies that reported on the 
implementation of a non-opioid first protocol in the ED (Cohen et al., 2015; Duncan et 
al., 2019). For one study, it was not apparent whether protocol use was mandated in all 
patients (Duncan et al., 2019). This is a limitation as it changes the significance of the 
findings. Both studies shared the two remaining limitations. First, neither of these studies 
are RCTs (Cohen et al., 2015; Duncan et al., 2019). The results of these studies are not as 
strong as a RCT. Secondly, the protocols in both studies include more analgesics than are 
available to EMS (Cohen et al., 2015; Duncan et al., 2019). This limits the ability to 
generalize the results of these studies to EMS. However, these studies demonstrate 
successful implementation of non-opioid first protocols that can guide changes in EMS.   
 
Importance and Use of Outcome Measures in the Reported Literature 
 While there are many outcome measures that can be important in considering an 
effective first-line treatment for acute pain in EMS, four important outcomes were 
identified for this literature review: effect on pain severity, patient satisfaction, rescue 
analgesic use, and the consideration of risks. The use of these outcome measures by the 
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17 RCTs that were not completely excluded in the Limitations of Reported Literature 
section are summarized in Table 4. Measuring the effect on pain severity requires an 
adequate pain assessment. In research, more objective measures typically provide more 
rigorous data. However, vital signs are not a reliable measure of pain intensity (Bossart et 
al., 2007; Ducharme, 2016; Jennings et al., 2009; Marco et al., 2006). In practice, pain 
scales are often utilized to measure pain severity (Table 4). Sixteen of the publications 
reported their results in terms of absolute reduction in pain scores.  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 62 
Table 4. Use of Four Identified Outcome Measures in Randomized Trials. Indicates 
the presence of each outcome measure in RCTs not excluded from use as evidence. 
 
Trial Effect on Pain Severity 
Patient 
Satisfaction 
Rescue 
Use 
Adverse 
Effects 
Comparison Studies 
Al et al. Absolute reduction No Yes Yes 
Bektas et al. Absolute reduction No Yes Yes 
Craig et al. Absolute reduction Yes Yes Yes 
Deloee et al. Absolute reduction No No No 
Eken et al. Absolute reduction No Yes Yes 
Farnia et al. Absolute reduction No Yes Yes 
Frey et al. Absolute reduction No Yes Yes 
Kariman et al. Absolute reduction No No Yes 
Miller et al. 
Absolute reduction 
Proportion obtaining 
percentage reduction 
No 
(Provider 
satisfaction is 
reported) 
Yes Yes 
Motov et al., 2015 
Absolute reduction 
Proportion obtaining 
percentage reduction 
Proportion ≥ 3-point 
reduction 
No Yes Yes 
Pathan et al. 
Absolute reduction 
Proportion obtaining 
percentage reduction 
Proportion ≥ 3-point 
reduction 
No Yes Yes 
Rainer et al. 
Absolute reduction 
Proportion obtaining 
percentage reduction 
Yes No Yes 
Serinken et al.  Absolute reduction No Yes Yes 
Shimonovich et al. Absolute reduction Yes No Yes 
Tran et al. 
Excluded in Limitations in 
Reported Literature section 
No No Yes 
Efficacy Studies 
Ducassé et al. 
Absolute reduction 
Proportion obtaining 
specified threshold 
Yes 
(Provider 
satisfaction 
also 
reported) 
No Yes 
Motov, 
Yasavolian, et al., 
2017 
Absolute reduction No Yes Yes 
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Although a study might report a statistically significant decrease in pain score, 
that does not inherently indicate a meaningful reduction in pain for the patients. One 
study reported that 13 mm is the minimum change in VAS to be considered clinically 
significant (Todd, Funk, Funk, & Bonacci, 1996). That study did not indicate whether the 
initial pain severity level affected this value. Another study reported 13 mm as the 
minimal clinically significant change only for patients with VAS scores less than 34 mm; 
patients with VAS scores at or above 67 mm required a 28 mm change in order to be 
clinically significant (Bird & Dickson, 2001).  
Instead of reporting results based on absolute pain reduction, seven studies also 
utilized different approaches (Table 4). These different assessment methods can 
demonstrate a reduction in pain severity or the percentage of patients achieving a 
specified goal. They serve as useful tools when comparing the ability of two analgesics to 
reduce pain, which is important in determining the most appropriate first-line treatment. 
The usefulness of these measures to identify adequate pain control is less clear. These 
types of goals do not completely consider how initial pain severity or other subjective 
factors may affect what a patient perceives as adequate analgesia. With the high 
prevalence of inadequate pain control, a measure of adequacy is an important outcome to 
consider.  
The physiologic nature of pain (signal input and modulation) through pain 
pathways and the perception of pain are the targets of analgesics. However, it would be 
impractical to assess the adequacy of pain by measuring the activity of these pathways. 
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This is because a multitude of factors play a role in the subjective pain experience beyond 
the more well understood physiology of pain (Coghill, 2010).  
Both patients and providers agree that an adequate pain goal should involve the 
patient, include realistic expectations and functional goals, be patient specific, and 
appropriately consider all aspects of the pain experience beyond solely relying on pain 
scales (American College of Emergency Physicians, 2017; Gunderson, 2011; Lee, 2016; 
Smith et al., 2015; The Joint Commission, 2017; University of Wisconsin Health Pain 
Care Services, n.d.). One way that this has been addressed in research is through the 
reporting of patient satisfaction. Despite its significance, only four of the publications 
included patient satisfaction as an outcome measure (Table 4). Two studies included a 
report of provider satisfaction with the analgesic treatment (Table 4).  
Realistic expectations and functional based pain goals may influence patient and 
provider satisfaction. For example, an initial prehospital goal may be to alleviate the pain 
enough for initial treatment and transport of the patient to be tolerable. A second goal 
may be to alleviate pain that is interfering with proper assessment. A patient’s 
understanding of what realistic pain management might look like may influence their 
pain goal and subsequently their reported satisfaction. None of the studies reviewed 
mentioned a script or dialogue with the patient to address the concept of realistic and 
functional pain management (Craig et al., 2012; Ducassé et al., 2013; J. P. Miller et al., 
2015; Rainer et al., 2000; Shimonovich et al., 2016). The differences in the baseline 
definition of satisfaction between groups was not indicated and therefore may have 
skewed the satisfaction results.    
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 The final useful measure of adequate pain management identified in this review is 
the use of rescue analgesics. In total, 11 of the publications recorded the percentage of 
patients in each group requiring rescue analgesia (Table 4). If a patient requires or 
requests a rescue analgesic, it can be inferred that the initial treatment was not considered 
adequate by the patient. A difference between group use of rescue analgesia is an 
indication that one treatment was more efficacious.   
 The last outcome measure is the consideration of risks associated with analgesic 
use. This is the combination of adverse effects, contraindications, and other factors. 
Adverse effects were reported in 16 of the studies (Table 4). While the previous outcome 
measures are arguably more important in deciding which treatment should be utilized as 
first-line treatment for acute pain in EMS, a significant difference in adverse effects 
between groups or the presence of specific undesired adverse effects for any one 
treatment may influence the final decision. This is especially true when the other outcome 
measures do not strongly favor one analgesic over the other.  
As noted in the Goal of Pain Management section, individual patient and/or 
healthcare provider preferences to avoid certain risks associated with a specific analgesic 
are both valid when deciding which treatment to utilize in a clinical setting. However, 
such personal preferences are not well integrated into comparison and efficacy RCTs as it 
would interfere with the randomization of the participants. That would be undesirable as 
randomization strengthens the validity of the results in an RCT.  
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DISCUSSION 
Pain is the oldest reported symptom (Meldrum, 2003). The high prevalence of 
pain make it likely that a wide variety of healthcare providers will treat patients reporting 
pain. EMS providers are no exception. Reports of pain prevalence in EMS patients vary 
in range from 42% to 53% (Galinski et al., 2010; Lord et al., 2009). The importance of 
pain management is also widely recognized (American College of Emergency 
Physicians, 2016; American Medical Association, n.d.; Brennan et al., 2016; Pizzo & 
Clark, 2012). With the high prevalence of pain and the recognition of the importance of 
adequate analgesia, it might be expected that optimal pain management strategies would 
be well understood and practiced. However, this is not the case. Pain management is 
often inadequate (Albrecht et al., 2013; American College of Emergency Physicians, 
2016; Baker, 2017; Brennan et al., 2016; Campbell, 1996). As such, improving pain 
management should continue to be a high priority for healthcare providers.   
 The two major groups of analgesics utilized in the prehospital setting are opioid 
and non-opioid analgesics. Opioids have long been used for acute pain management in 
the prehospital setting. Non-opioids are a more recent addition and have gain increased 
attention in the wake of the opioid epidemic. This literature review seeks to determine if 
non-opioid analgesics can be utilized as first-line treatment for acute pain in the EMS 
environment.  
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Results of Outcome Measures in the Reported Literature 
 There are four broad results possible for each outcome measure. The result may 
not be reported by a study. The result may be reported, but the statistical significance 
may not be reported. One analgesic may be favored over the other as demonstrated by the 
results within an outcome measure. The final possible result is that no significant 
difference is found between the study groups. While no significant difference is not the 
same as equivalence, it indicates that neither group is superior to the other for the 
outcome being measured. This finding is significant when considering an alternative to 
the standard of care for acute pain, opioid analgesics.     
There are some considerations that are unique to EMS and are also significant 
when selecting a first line treatment for acute pain management by prehospital providers. 
These considerations apply to all the non-opioid analgesics investigated in this section. In 
EMS, there is typically only one provider with the patient in the ambulance during 
transport. The single provider must perform all patient care tasks during transport. These 
tasks include assessing, monitoring, and treating the patient, and managing adverse 
effects. The confined space of the ambulance coupled with the additional noise and 
movement associated with transportation increase the difficulty of successfully managing 
the heavy task load. The most critical cases, including cardiac arrest, may result in more 
providers present during transport. However, significantly more tasks are also performed 
in these critical cases. This contrasts with the ED where there are frequently additional 
providers (nurses, technicians, physicians, etc.) who assist with different aspects of 
patient care if needed.  
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There are also additional considerations regarding resource availability, 
education, scope of practice, and culture of EMS. The limited availability of resources 
extends beyond the number of providers present during transport. Prehospital providers 
have limited equipment available for diagnostic testing. This complicates the creation of 
protocols that adequately address the various contraindications and indications for 
administering certain analgesics, and other medications. As will be more fully discussed 
in later sections of the review, the culture of EMS practice is heavily protocol driven. 
This is in part related to the limited educational training and scope of practice of 
prehospital providers and contrasts with the extensive training and more free form 
decision making process that is typical of physicians. As a result, these unique 
characteristics have a significant role when considering analgesic administration by EMS. 
These EMS circumstances will be considered throughout the remaining sections of the 
review as it applies to each analgesic. 
 
Non-Opioid Studies, Excluding Ketamine: 
 After the exclusions made in the Limitations in Reported Literature section, there 
are three non-opioids (acetaminophen, ketorolac, and nitrous oxide) and nine comparison 
studies remaining. One study was mentioned in that section, but wasn’t excluded (Al et 
al., 2018). While the results of this study did not demonstrate a significant difference, it 
should be reiterated that the limitation favored fentanyl due to a low dose of 
acetaminophen. The remaining studies administered doses that are representative of EMS 
protocols. The initial pain scores of most studies were in the top quarter of the pain scale, 
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which contributes to the generalizability of the results. If an analgesic is effective for 
severe pain, it is a safer generalization that it would be effective for lower levels of pain 
than generalizing studies with low initial pain scores to high pain severity patients. These 
studies can be separated into two groups: pain from renal colic and pain from trauma.   
An aspect of the unique circumstances of EMS favors all three of the non-opioid 
analgesics in this subsection. The adverse effects outcome measure may be more 
significant in EMS than in the ED. More adverse effects increases the total tasks the 
single EMS provide must perform during transport. Opioids are known to have more 
adverse effects than these three non-opioids. Adverse effects of opioids, such as emesis, 
hypotension, and respiratory depression, require additional management and monitoring 
of the patient. The non-opioid analgesics may be preferred as they have fewer adverse 
effects and reduce the total task load of the provider.    
Acetaminophen is the only non-opioid represented in the renal colic group (Table 
5). Only one study demonstrated significant differences between groups for the effect on 
pain severity outcome measure, all of which favored acetaminophen to varying degrees. 
One study reported that the morphine group used more rescue analgesia than the 
acetaminophen group. Two of the studies reported significantly more adverse effects in 
the morphine group. Pathan et al. analyzed approximately 440 patients per group, which 
significantly strengthens the results of that study (Pathan et al., 2016). Overall, all three 
of the four outcome measures utilized in these studies favor acetaminophen over opioid 
analgesics.  
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Table 5. Results of Four Outcome Measures in Non-Opioid Comparison Studies 
Investigating Acute Renal Colic Related Pain, Excluding Ketamine. APAP – 
Acetaminophen, NR – Not Reported, NSD – No Significant Difference, PS – Patient 
Satisfaction, SSNR – Statistical Significance Not Reported.  
Trial Groups Effect on Pain Severity PS Rescue Use 
Adverse 
Effects 
Al et al. 
Acetaminophen 
Fentanyl 
NSD NR SSNR SSNR 
Bektas et 
al. 
Acetaminophen 
Morphine 
NSD NR NSD NSD 
Serinken 
et al. 
Acetaminophen 
Morphine 
NSD NR NSD 
Morphine 
significantly 
more 
(14.3% vs. 
5.3%) 
Pathan et 
al. 
Acetaminophen 
Morphine 
Percent patients achieving 
50% reduction by 30 min 
greater for APAP (68% vs. 
60%) 
Mean score at 30 min lower for 
APAP (3.3 vs. 3.8) 
Reduction of at least 3-points - 
SSNR 
Percent patients with pain at 
60 min less for APAP (30% vs. 
38%) 
NR 
Morphine 
significantly 
more (23% 
vs. 20%) 
Morphine 
significantly 
more (3% 
vs. 1%) 
 
In the case of renal colic, there are other factors that strengthen the findings in the 
literature. Non-opioids are currently recommended as first line treatment over opioids for 
acute pain from renal colic (Engeler, Schmid, & Schmid, 2008). It should be noted that 
within non-opioids, the current recommendations favor NSAIDs over acetaminophen. As 
mentioned in the Pharmacologic Pain Treatments: Opioids and Non-Opioids section, 
opioids are known to have more adverse effects and contraindications compared to 
acetaminophen, which can be given to most any patient. The relative lack of 
contraindications for acetaminophen is important given the limited diagnostic testing 
equipment available to EMS. In addition, the fixed adult dosing of acetaminophen avoids 
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the calculation of a weight-based dose in the hectic EMS environment. This is 
advantageous as it reduces the task load of the EMS provider. 
None of the other non-opioids, excluding ketamine, considered in this literature 
review investigated renal colic pain. Therefore, there is not enough evidence to support a 
general recommendation that non-opioids, as a group, be utilized as first line treatment 
for the treatment of acute renal colic pain in EMS. There were three outcome measures 
available in the four renal colic studies. All three favored acetaminophen to varying 
degrees and were strengthened by other factors outside of the reported comparison 
studies. There is enough evidence in this literature review to support using 
acetaminophen over opioids for acute renal colic pain in EMS. Acute renal colic pain 
should be treated by EMS using analgesics, excluding ketamine, in the following order: 
NSAIDs, acetaminophen, opioids. 
One significant limitation of this recommendation pertains to the limited ability of 
EMS to diagnose renal colic. The recommended equipment for definitive diagnosis 
include computed tomography (CT) scans and ultrasound (Carter & Brown, 2017). 
Although ultrasound has been studied for use in EMS, it is not commonplace. EMS 
providers must rely on patient report, if a current diagnosis of renal colic has already been 
given, or signs and symptoms. These usually include unilateral acute onset flank pain that 
may radiate to the groin, ipsilaterally (Carter & Brown, 2017). In addition, approximately 
90% of cases will present with hematuria (Carter & Brown, 2017). Hematuria is reliant 
on the patient recognizing and reporting it to EMS, which may present a limitation for 
that presentation of renal colic. Careful recognition of these signs and symptoms, and 
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specific exclusions such as associated trauma, may provide enough of an indication to 
base treatment on. 
There are five studies investigating trauma related pain (Table 6). All four 
outcome measures are represented in this group of studies. The effect on pain severity 
outcome measure is variable in this group. Two studies demonstrate three outcomes that 
favor the non-opioid analgesics. However, the study by Kariman et al. does not report if 
their outcome favoring nitrous oxide is clinically significant (Kariman et al., 2011). There 
are also two studies that favor the opioid analgesic at the first assessment. The 11 mm 
difference observed in one study favoring the opioid analgesic is below the clinically 
significant threshold noted by two different studies (Bird & Dickson, 2001; Todd, Funk, 
Funk, & Bonacci, 1996). That result is unlikely to represent a meaningful reduction for 
the patient. The 14.5 mm difference favoring an opioid demonstrated in the other study 
may represent a meaningful reduction for the patient using the 13 mm threshold (Todd et 
al., 1996). However, the 14.5 mm difference is below the 28 mm threshold given the high 
initial pain severity (Bird & Dickson, 2001). Taking this into consideration, two pain 
reduction outcomes favor the non-opioids and one may favor the opioids. 
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Table 6. Results of Four Outcome Measures in Non-Opioid Comparison Studies 
Investigating Acute Trauma Related Pain, Excluding Ketamine. NR – Not Reported, 
NSD – No Significant Difference, PS – Patient Satisfaction. 
Trial  
(Source of 
Pain) 
Groups Effect on Pain Severity PS 
Rescue 
Use 
Adverse 
Effects 
Deloee et al. 
(Isolated 
diaphyseal 
long bone 
fracture) 
Acetaminophen 
Morphine 
14.5 mm difference in 
reduction at 5 min 
favoring morphine 
NSD at 30 min 
NR NR NR 
Craig et al. 
(Isolated limb 
trauma) 
Acetaminophen 
Morphine 
NSD NSD NSD 
Morphine 
significantly 
more (8 vs. 
2 patients) 
Eken et al. 
(Mechanical 
low back) 
Acetaminophen 
Morphine 
11 mm difference at 15 
min favoring morphine 
NSD at 30 min 
NR NSD NSD 
Rainer et al. 
(Non-
penetrating 
Isolated limb 
trauma) 
Ketorolac 
Morphine 
Odds of 75% reduction 
with activity favors 
ketorolac. NSD for 50% 
(100% NR) nor at rest 
for 50%, 75%, 100%. 
Per hour rate of 
reduction greater for 
ketorolac with activity 
(1.09 vs. 0.87). NSD at 
rest. 
Favors 
ketorolac 
NR 
16 times 
more likely 
for morphine 
Kariman et 
al. (Isolated 
extremity 
fracture or 
dislocation) 
Nitrous oxide 
Fentanyl 
Mean score for nitrous 
oxide significantly less at 
9 min (2.2 vs. 3.1)  
NSD at 3 and 6 min 
NR NR NSD 
 
  
 Although there is only one study reporting a limitation of non-opioid use due to a 
slower onset of analgesia, this limitation is potentially significant in the context of EMS. 
Many EMS systems have short transport times. For example, an urban city likely has 
most transports under 10 minutes while a suburban city may have transport times that 
extend to 15 or 20 minutes. Only rural EMS systems are likely to have extended 
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transports beyond 30 minutes. The short transport times increase the importance of 
administering an analgesic with rapid onset. The coadministration of another non-opioid 
analgesic with acetaminophen may mitigate the potential limitation, although small in 
magnitude, reported by the one study.    
 The study investigating ketorolac reported two outcomes that indicated ketorolac 
was superior to morphine when patients moved their injured extremity (Table 6). Another 
unique aspect of EMS is that the patient is transported in a moving vehicle. The transport 
is often jarring for the patient. In addition, significant movement of the patient may be 
required at the scene of the emergency to get the patient onto the stretcher and loaded into 
the ambulance. It would be advantageous to have an analgesic, such as ketorolac, that is 
known to significantly outperform opioid analgesics when the patient is moving.  
The use of rescue analgesia does not favor either group of medications (Table 6). 
One of the two studies reporting patient satisfaction demonstrated a significant 
difference; patients are more satisfied with the non-opioid analgesic. The EMS study 
investigating nitrous oxide in trauma patients found that all but one patient and all but 
two providers were satisfied or very satisfied with the non-opioid treatment (Ducassé et 
al., 2013). This additional information strengthens the support for non-opioid analgesics 
in EMS. Adverse effects are reported in four of the studies, two of which found morphine 
to have significantly more adverse effects. This finding parallels the known adverse 
effects profiles noted in the Pharmacologic Pain Treatments: Opioids and Non-Opioids 
section. 
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 There are additional external factors that contribute to the reported literature. The 
task load by EMS providers is reduced when these non-opioid analgesics are selected due 
to the fixed dosing. Nitrous oxide has an additional benefit that it is self-administered by 
the patient and does not require IV/IM/IN/IO administration. This allows the patient to 
control the level of analgesia administered and allows the patient to self-limit any adverse 
effects that may be experienced. These advantages are not possible with opioid analgesia 
in EMS as patient controlled analgesia devices for opioids are not commonly found in 
this setting.        
 All four outcome measures are utilized in the studies investigating acute pain 
from a chief complaint that is traumatic in nature. Non-opioid analgesics are marginally 
favored in their ability to decrease the pain severity. A potential solution exists to address 
the possible limitation of acetaminophen having a slower analgesic effect. While neither 
group of analgesics are superior in the number of patients requiring rescue analgesia, the 
non-opioid analgesics are favored both in terms of patient satisfaction and the 
consideration of risks. Non-opioid analgesics are also favored in various factors that 
consider the aspects unique to EMS. Although there are limitations in the generalizability 
of these results, as discussed in the Limitations in Reported Literature section, there is 
enough evidence to support a more specific recommendation. The use of acetaminophen, 
ketorolac, and nitrous oxide as first line treatment by EMS for patients with acute pain 
resulting from an isolated extremity trauma is supported. While not the focus of this 
review, coadministration of non-opioid analgesics is a reasonable consideration to 
maximize the analgesic effect.  
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Ketamine Studies: 
 None of the six ketamine studies were completely excluded in the Limitations in 
Reported Literature section. As mentioned in that section, five of the studies support 
conclusions for patients 18 years old and older and the final study provides significant 
evidence to state a pediatric conclusion. There was more diversity in the route of 
administration studied in the six different ketamine RCTs than the other non-opioid 
RCTs. IN/IV ketamine, IN fentanyl, and IM/IV morphine were all represented between 
the six studies (Table 7 and Table 8). The ability to use the IN route is particularly useful 
in patients where it may be difficult or especially distressing to obtain IV access, such as 
pediatric patients. However, fentanyl can also be administered IN so route of 
administration alone does not favor ketamine over the opioid analgesics. 
The consideration of risks outcome measure is more complex for ketamine 
compared to the other non-opioids. The adverse effects results are comparable between 
the pediatric and adult ketamine studies. As such, the consideration of risks for both 
groups will be considered simultaneously. As mentioned in previous sections, ketamine is 
a controlled substance with the potential for abuse. In the United States, ketamine is listed 
as a Schedule III drug, which means it has at most a moderate potential for dependence, 
both physical and psychological (United States Drug Enforcement Administration, n.d.). 
This is important to note, as one of the driving factors in the search for opioid alternatives 
is the pressures placed on the ED and EMS to find alternatives to opioids as a result of 
the opioid epidemic. However, by function of its classification, there is less potential for 
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ketamine abuse than opioids. Morphine and fentanyl, which are Schedule II drugs, have a 
high abuse and dependence potential (United States Drug Enforcement Administration, 
n.d.). While the potential for abuse is less in ketamine, it still exists. The other non-
opioids, such as acetaminophen and ketorolac, are not controlled substances and do not 
pose a risk of abuse. There may be cases where the opioids, ketamine, and the other non-
opioids could all be equally considered as first line treatment after considering all other 
outcome measures. In these cases, it is reasonable to suggest that analgesics be selected 
based on the consideration of risks outcome measure barring any specific 
contraindications related to other risks. That order begins with the other non-opioids, 
followed by ketamine, and lastly, the opioids.  
The other risks to consider for ketamine are its known effects, which are typically 
reported in studies investigating ketamine. The adverse effects reported for ketamine 
include reemergence reactions including hallucinations, dizziness, hypersalivation, 
nausea, emesis, sedation, and laryngospasm (Ducharme, 2016; Green et al., 2009; Kurdi 
et al., 2014; Motov, Mai, et al., 2017; Pourmand et al., 2017; Wedmore & Butler, 2017). 
These adverse effects must be weighed against the common adverse effects of the opioid 
analgesics, especially morphine, which include hypotension, respiratory depression, 
euphoria, sedation, and constipation (Abdel-Aziz & Adams, 2017; Ducharme, 2016). The 
most concerning of the opioid analgesics are the respiratory depression and 
hemodynamic effects. Ketamine is favored in this regard as its effects on respiratory 
drive are minimal and it is known to stimulate the sympathetic nervous system resulting 
in increased blood pressure, heart rate, and cardiac output (Kurdi et al., 2014).  
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All six of the ketamine RCTs reported some variation in the comparison of 
adverse effects (Table 7 and Table 8). Two studies reported that the ketamine group 
experienced significantly more minor adverse effects than the morphine or fentanyl 
group, but that the difference was soon after administration and transient. Three studies 
reported that specific adverse effects are more prevalent in one analgesic or the other with 
no significant trend favoring either analgesic (Table 8). 
The initial increase in adverse effects may be related to the rapid administration of 
the medication. A study comparing ketamine administered via an IV push over 5 minutes 
to an IV infusion over 15 minutes demonstrated a significant reduction in adverse effects 
when the administration time was increased without any significant difference noted in 
analgesic effect or rescue analgesic use (Motov, Mai, et al., 2017). This suggests that the 
initial prevalence of adverse effects of ketamine can be reduced by changing the 
administration time. In the United States, the state of Vermont already requires a 15 
minute infusion when ketamine is used by EMS providers for pain management 
(Vermont Department of Health Office of Public Health Preparedness and Emergency 
Medical Services, 2018). Notably, the 15-minute infusion should not require the use of an 
infusion pump, which is not common in EMS. The manual IV administration sets 
commonly used by EMS providers have a predefined drops per milliliter rate (gtt/mL) 
that can be used to set a 15-minute infusion. The short transport time previously noted for 
urban EMS systems may result in arrival at the ED prior to the completion of the 
infusion. This is likely to be of limited concern because no significant difference in 
analgesic efficacy was found between the administration times (Motov, Mai, et al., 2017). 
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Furthermore, it may be advantageous to have time remaining at the ED to bridge the gap 
between prehospital care and analgesic administration by an EM provider. This gap is 
created due to the time it takes for registration, assignment to a bed, and the time between 
the physician’s order for analgesic administration and actual administration of an 
analgesic. 
Overall, ketamine does not have the benefit of reduced task loading on EMS 
providers noted for the other non-opioid analgesics. The preservation of the respiratory 
drive, lack of hypotension, and reduced potential for abuse are all advantages of 
ketamine. The lack of hypotension and potential for an increase in the sympathetic 
nervous system may actually delineate significant benefits for ketamine. This is 
especially true for patients where hypotension or an increased concern for hypotension 
may contraindicate opioid analgesic use by EMS. In addition, the ability to reduce the 
early adverse effects using a slower infusion without sacrificing analgesic efficacy 
mitigates the one major concern reported by the ketamine studies for the consideration of 
risks outcome measure when IV ketamine is administered. The various factors pertaining 
to the consideration of risks outcome measure supports the recommendation for a 15-
minute infusion time when IV ketamine is used by EMS for pain management.  
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Table 7. Results of Four Outcome Measures in a Pediatric Ketamine Comparison 
Study Investigating Acute Trauma Related Pain. Fent – Fentanyl, IN – Intranasal, Ket 
– Ketamine, NR – Not Reported, NSD – No Significant Difference, PS – Patient 
Satisfaction. 
Trial 
(Source of 
Pain) 
Groups Effect on Pain Severity PS 
Rescue 
Use 
Adverse Effects 
Frey et al. 
(Extremity 
injury) 
IN: 
Ketamine 
Fentanyl 
Ket non-inferior to fent in 
reduction at 30 min 
NSD in mean difference 
from baseline 
NSD in lowest pain 
scores achieved 
NR NSD 
All minor and transient. 
Larger overall proportion in 
ket (77% vs. 31%). NSD 
except at 15 min.   
NSD in max sedation 
score 
NSD in vital signs. 
 
The one study exclusively investigating extremity trauma in a pediatric population 
will be considered separately for the remaining outcome measures (Table 7). Although it 
wasn’t a large study, it was the only RCT to utilize a non-inferiority design (Frey et al., 
2019). This style of design provides more significant evidence than a superiority design 
(when superiority is not demonstrated) because a lack of superiority does not equate to 
equivalence or non-inferiority. In this case, ketamine was not inferior to fentanyl in all 
pain severity measures. The study acknowledged the use of higher doses of medication in 
both groups, but mentioned that it did not result in increased analgesic effect compared to 
previous studies (Frey et al., 2019). This finding is important when generalizing to EMS 
due to the lower doses of both medications that are used in that setting. The high initial 
pain score, as mentioned previously, also supports generalizability.  
Patient satisfaction was not reported (Table 7). However, no significant difference 
was found for rescue analgesic use. The strength of the non-inferiority design coupled 
with the consideration of risks previously discussed allows a specific recommendation to 
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be made based on these results. In the pediatric population suffering from acute pain after 
an extremity injury, ketamine should be considered by EMS for use as first line treatment 
over opioid analgesics. This suggestion is strengthened in patients where the concern for 
the hemodynamic and respiratory drive effects of opioids or the concern for opioid 
addiction relapse or opioid tolerance is greater. 
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Table 8. Results of Four Outcome Measures in Ketamine Comparison Studies 
Investigating Acute Pain. HCP – Healthcare Provider, IM – Intramuscular, IN – 
Intranasal, IV – Intravenous, Ket – Ketamine, Mor – Morphine, NR – Not Reported, NSD 
– No Significant Difference, PS – Patient Satisfaction. 
Trial  
(Source of 
Pain) 
Groups 
Effect on Pain 
Severity 
PS 
Rescue 
Use 
Adverse Effects 
Farnia et al. 
(Renal colic) 
IN:  
Ketamine 
IV:  
Morphine 
Mean difference 
between groups at 5 
min favors mor (7.9 
mm difference). NSD 
at 15 and 30 min. 
NR NSD 
Hypotension in 8 mor 
and 
emergence in 6 ket 
patients 
Miller et al. 
(Extremity, low 
back, flank, 
abdominal) 
IV:  
Ketamine 
Morphine 
Max reduction: 
Ket (-4.9 at 5 min) 
Mor (-5 at 100 min) 
Ket mean percent 
reduction 
approximately 50% for 
2 hours despite poor 
sustained analgesia 
NR 
 
NSD 
for 
HCP 
NSD 
NSD overall 
NSD in agitation and 
sedation 
Systolic blood 
pressure higher for 
ketamine at 5 and 10 
min  
Motov et al., 
2015 (Musculo-
skeletal, back, 
flank, 
abdominal) 
IV:  
Ketamine  
Morphine 
Ket 31% more 
complete resolution at 
15. NSD at 30 min. 
NSD in reduction at 15 
and 30 min 
NSD in percent 
achieving at least 3-
point reduction 
NR 
Ket 17% 
more at 
120 min. 
NSD at 
30 and 
60 min. 
Only minor effects. 
Difference favors mor 
at 15 min (38% 
difference). NSD at 30 
min.   
Shimonovich 
et al. (Mild to 
moderate blunt 
trauma) 
IN:  
Ketamine 
IV:  
Morphine 
IM:  
Morphine 
IN ket faster rate of 
reduction than IM mor 
until NSD at 45 min 
NSD in rates of 
reduction for IV mor 
and IN ket 
NSD in max reduction 
or time to reach max 
NSD NR 
Difficulty concentrating 
IN ket more than IV/IM 
mor (58.3% vs. 
20.8%/22.2%).  
Dizziness IN ket more 
than IM mor (79.2% 
vs. 22.2%).  
Confusion IN ket more 
than IV mor (50% vs. 
12.5%).  
Dry mouth IV/IM mor 
more than IN ket 
(79.3%/63% vs. 25%) 
NSD in vital signs 
Tran et al. 
(Trauma) 
IV:  
Ketamine 
IM: 
Morphine 
Excluded in 
Limitations in 
Reported Literature 
section 
NR NR 
More nausea and 
emesis for mor (19% 
vs. 5%; difference of 
8-22%).  
More agitation for ket 
(11% vs. 1.5%; 
difference of 4-16%) 
 83 
The remaining five studies covered a broad range of acute pain, both traumatic 
and non-traumatic in nature, in an adult population (Table 8). As previously mentioned, 
the doses used are generalizable to EMS and the high initial pain scores are an added 
strength of the studies. Overall, ketamine is found to have a significantly more rapid 
onset of analgesic effect compared to opioid analgesics (Table 8). One study reported the 
opposite finding. However, the difference reported was 39% lower than the 13 mm 
clinically significant difference threshold (Bird & Dickson, 2001; Todd et al., 1996). As 
mentioned in the discussions regarding the other non-opioids, a rapid onset of action is 
advantageous for EMS.  
One limitation reported in two studies, one via effect on pain severity and one via 
rescue use, is that ketamine does not provide sustained analgesia as well as the opioid 
analgesics (Table 8). Despite these results, Miller et al. found that the mean percentage 
reduction in pain score was still at least 50% for two hours in the ketamine group. In 
addition, one study reported that IN ketamine and IV morphine have similar rates of 
reduction (Table 8). This is an important finding as it demonstrates the analgesic efficacy 
of ketamine administered via the IN route compared to an IV route of administration for 
an opioid. An IN analgesic can be administered more quickly and is less invasive than an 
IV analgesic. This is especially pertinent in patients where an IV access is difficult to 
obtain. The rescue use result was only significant at the 120-minute assessment (Table 8). 
This result is not significant for most EMS systems. A 120-minute transport time would 
be an abnormally long transport for the typical United States EMS system. As such, this 
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specific result is not well suited to generalize to EMS use of ketamine. The other rescue 
analgesic results and the satisfaction results did not favor either medication.  
In the five adult ketamine RCTs included, all four of the outcome measures were 
utilized in at least one RCT. After considering the unique circumstances of EMS, only 
two outcome measures had enough evidence to favor one analgesic over the other. The 
consideration of risks, although more complicated for ketamine compared to the other 
non-opioids, favors ketamine over the opioid analgesics. The effect on pain severity 
outcome measure also favors ketamine. Due to diversity in the locations and causes of 
acute pain studied in ketamine, a more general statement can be supported for adult 
patients. In adult patients, ketamine should be considered by EMS for use as first line 
treatment over opioid analgesics. Just as in the pediatric population, this suggestion is 
strengthened in patients with increased concern for opioid addiction relapse or opioid 
tolerance and in patients whose hemodynamic or respiratory status may increase the risk 
of opioid analgesic use. 
 
Applicability of Recommendations to EMS 
 All the studies reported in this review were performed by higher level providers 
with a scope of practice and education beyond the EMS paramedic. Within the United 
States, most Advanced Life Support EMS providers operate under the license of a 
medical director, who is a physician. Most medical directors and EMS services are 
required to follow statewide protocols, also written and presided over by physicians. 
Standing orders, written in a protocol document, govern the scope of practice for each 
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EMS provider level. Most patient care by EMS is performed utilizing these protocols. 
The EMS provider can also contact online medical direction, typically a phone call to an 
affiliated physician, to request additional orders or input. The EMS provider’s limited 
scope of practice and lack of an independent license necessitate rigid protocols that 
account for the knowledge, skillset, and equipment that each level of provider has access 
to. As mentioned in the introduction, paramedics represent the most advanced level of 
EMS provider for this review and can utilize all the recommendations. 
 Protocols must also consider another unique aspect of EMS care. EMS often 
interacts with undifferentiated patients. While EM also cares for undifferentiated patients, 
EMS is unique in that the limited resources hinder diagnostic evaluation. This has 
implications for EMS protocols and the non-opioid analgesic recommendations. The 
recommendations made in this review would have to be written into protocols that 
consider these unique aspects of EMS practice. 
 Perhaps the most significant consideration in writing rigid protocols based on 
these recommendations is including appropriate and explicitly defined inclusion and 
exclusion criteria that only utilizes resources available to EMS. This presents a barrier to 
the implementation of the research findings because many of the studies utilized blood 
work and other imaging technologies (ultrasound, X-Ray, CT, etc.) in their research 
protocols. The different non-opioid analgesics included in the recommendations are 
acetaminophen, ketorolac, nitrous oxide, and ketamine. They each have varying 
contraindications that have been previously discussed in detail. All four non-opioids are 
currently utilized in at least one EMS system in the United States. The state protocols of 
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these EMS systems provide reference for the contraindications of these analgesics in 
ways that are appropriate for EMS administration (Alabama Department of Public Health 
Office of Emergency Medical Services, 2018; Massachusetts Department of Public 
Health Office of Emergency Medical Services, 2017; Vermont Department of Health 
Office of Public Health Preparedness and Emergency Medical Services, 2018).   
 The two specific etiologies resulting in pain represented in the recommendations 
of this review are renal colic and extremity trauma. Extremity trauma, without further 
explanation, is a sufficient inclusion parameter for EMS providers. The identification of 
renal colic cannot be definitively made in the prehospital setting. However, a protocol 
could be written to allow for the use of non-opioid analgesics in patients with a high 
index of suspicion for renal colic. This protocol may include the presence of flank pain 
not associated with trauma and difficulty or pain with urination. Of course, patients who 
state their pain is from a current diagnosis of renal colic would also be indicated. The 
adult ketamine recommendation is more general in nature and does not require rigid 
etiology-based inclusion criteria.  
 The development of non-opioid first protocols is only one aspect of implementing 
these recommendations in EMS. Changes and updates to pain management education 
would likely improve the result of new protocols on acute pain management in EMS. 
Both studies reporting on a non-opioid first protocol incorporated provider education 
(Cohen et al., 2015; Duncan et al., 2019). Based on the topics discussed throughout this 
review, it is reasonable to propose that EMS provider education should include the 
following outcomes: 
 87 
1. Awareness of high prevalence of acute pain and inadequate analgesia. 
2. Awareness of the importance of pain management. 
3. Describe the pain experience including the subjective nature of pain. 
4. Perform a comprehensive pain assessment and understand the limitations of pain 
scales. 
5. Discuss realistic pain management expectations and goals with patients. 
6. Understand the relative advantages and disadvantages of each analgesic. 
7. Appropriately utilize non-opioid and opioid analgesics including an understanding 
of certain indications where non-opioid analgesics should be successfully 
administered as first-line treatment. 
8. Understand the potential implications of EMS provided pain management on the 
entire patient experience. 
 
Given the scarcity of EMS research on acute pain management outcomes, only 
the potential impact on the entire patient experience can be discussed. The first situation 
to consider is the exclusive use of opioid analgesics by EMS. This is likely to result in 
continued inadequate pain management. Many patients with minor to moderate pain may 
not be offered a potent analgesic such as morphine or fentanyl. Also, only paramedics 
will have access to an analgesic. The patients who are given analgesics will only receive 
opioids. This presents a potential limitation in patients concerned with relapse, patients 
who have developed an opioid tolerance or are taking medications such as methadone, or 
patients where opioid analgesics may be contraindicated.  
Only having opioid analgesics available also limits the ability of the EMS 
provider to include the patient in the pain management process, which was identified as 
an important component from the patient perspective (R. J. Smith et al., 2015). Treating 
all patients with opioids may also lead to an unrealistic expectation that more opioids 
should be given by the physician in the ED. However, the EM physician has access to 
non-opioid analgesics in addition to opioid analgesics. The ED provider may believe that 
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a non-opioid analgesic is the preferred choice for a patient. The unrealistic expectation 
resulting from opioid use by EMS may increase the difficulty of discussing non-opioid 
options in the ED. The pressure to continue with opioid treatment may also be increased 
due to the implications on healthcare reimbursement mentioned in the Goal of Pain 
Management section.    
Pressures to continue opioid treatment in the ED may also increase the potential 
for a short course opioid prescription upon discharge. Two studies presented in the 
Pharmacologic Pain Treatments: Opioids and Non-Opioids section reported a potential 
contribution of opioid exposure or prescription for acute pain in the ED to future 
recurrent use or abuse (Butler et al., 2016; Hoppe et al., 2015). This potential for abuse is 
receiving increased attention due to the opioid epidemic in the United States. 
Recommending non-opioid use by EMS has the potential to address all these concerns 
and provide additional benefits. 
EMS administration of non-opioid analgesics should allow for increased 
treatment of any severity of pain, increased patient involvement in pain management, 
discussion of realistic expectations and appropriate goals, and provide an alternative for 
patients at a higher risk with opioid analgesic use. The prehospital initiation of non-
opioid treatment and discussion of realistic pain management will mitigate the barriers 
present upon arrival to the ED in the previous scenario. The availability of non-opioid 
analgesics may also allow EMTs and AEMTs to administer pharmacologic analgesia. 
Some states in the United States currently allow specific non-opioid analgesic 
administration by EMTs and AEMTs (Alabama Department of Public Health Office of 
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Emergency Medical Services, 2018; New Hampshire Department of Safety Division of 
Fire Standards and Training and Emergency Medical Services, 2018; Vermont 
Department of Health Office of Public Health Preparedness and Emergency Medical 
Services, 2018). A final benefit to non-opioid use is that fewer resources are required to 
manage patients receiving non-opioids, possibly except for ketamine, compared to 
opioids. One of the comparison studies reported that patients in the ED receiving a non-
opioid were discharged more quickly, did not require as many resources to manage 
adverse effects, and resulted in lower ED and pharmacy costs (Rainer et al., 2000). These 
potential advantages warrant significant consideration of non-opioid analgesic use by 
EMS.   
 
Application of Non-Opioid First Protocols in Practice 
 There are two studies that reported on a non-opioid first protocol being 
implemented in the ED (Cohen et al., 2015; Duncan et al., 2019). In one study a 20% 
reduction in IV opioid use was reported along with a 29.5% increase in acetaminophen 
use and a 73.7% increase in ketorolac use (Duncan et al., 2019). Importantly, Duncan et 
al. reported no significant difference in patient satisfaction before or after the 
implementation of the protocol. The Colorado chapter of the ACEP includes the non-
opioid first protocol used by Duncan et al. in their 2017 guidelines (Colorado Chapter of 
the American College of Emergency Physicians, 2017).  
The other study only had 17 patients, but all were treated with the non-opioid first 
protocol (Cohen et al., 2015). Interestingly, by 30 minutes, 41% of patients had at least a 
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30% reduction in pain, 83% were satisfied with their pain relief, and only one patient 
throughout the entire study period received rescue analgesia. This is with a median initial 
pain score of 8 out of 10. Ketorolac, acetaminophen, and oral ibuprofen were the three 
most common analgesics administered (Cohen et al., 2015). As mentioned in the 
Limitations in Reported Literature section, the generalizability of these results to EMS is 
limited due to the use of a wide variety of analgesics not available to EMS. 
Despite the limitations, both studies demonstrate the success of a non-opioid first 
protocol. These studies, the current recommendations made, and the discussion regarding 
the application of the recommendations to EMS in conjunction with the information 
presented throughout this review presents compelling evidence that non-opioid analgesics 
should be administered as first-line treatment by EMS in specific situations. A potential 
EMS protocol incorporating considerations made throughout this review and allowing for 
the application of all recommendations made is presented in Figure 1. Only specific 
information supported by the review is included in the protocol. Although one of the 
recommendations allowed for use in patients 16 years old and older, the figure only 
delineates between adult (18 years and older) and pediatric (under 18 years old) to 
simplify the EMS protocol. This protocol would be added in addition to the existing pain 
management protocols for an EMS system that details the contraindications and 
additional doses and routes of administration allowed for each analgesic. As mentioned 
previously, education should be provided to the EMS providers to maximize the benefit 
the protocol may have to patients.  
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Figure 1. EMS Acute PAIN Analgesic Priorities. EMS specific Pain Algorithm 
Integrating Non-opioids (PAIN) that applies information contained in this review; 
intended as an adjunct to a preexisting pain management protocol. IN – Intranasal, IV – 
Intravenous.   
EMS Acute PAIN Analgesic Priorities     PAIN: Pain Algorithm Integrating Non-opioids 
Important: Indicated in patients reporting acute 
pain. Contraindicated in cardiac related pain. 
Step 1  Determine Starting Point 
Any apply, start at Step 3. None apply, Step 2. 
• Patient is in extremis 
• Patient sustained multisystem trauma 
Step 2  Etiology Based Treatment Recommendations 
Pediatric Adult 
Renal 
Colic 
Isolated 
Extremity 
Trauma 
Extremity 
Trauma 
1st Line: NSAIDs (eg. Ketorolac) 
2nd Line: Acetaminophen 
3rd Line: Ketamine 
4th Line: Opioids per existing protocol 
1st Line: Acetaminophen, ketorolac, nitrous oxide 
2nd Line: Ketamine 
3rd Line: Opioids per existing protocol 
1st Line: Ketamine 
2nd Line: Opioids per existing protocol 
Step 3  Consideration of Risks Based Treatment Recommendations 
Existing 
Protocol 
Allows 
Opioids 
Opioid has 
Increased 
Risks 
Due to 
Hypotension 
Use existing protocol 
1st Line: Ketamine 
Consider ketamine instead of opioids 
Proceed to Step 3 
Doses: Check for contraindications 
Acetaminophen: 1000 mg IV 
Ketorolac: 10 mg IV 
Nitrous oxide: 50% administered by patient  
Ketamine: 0.3 mg/kg IV over 15 minutes or 1 
mg/kg IN 
Note: May consider other doses/routes if 
existing protocols allow. 
Yes 
Notes   
• Renal colic: typically, acute onset unilateral flank pain, may radiate to groin ipsilaterally, and 
hematuria present in most cases. 
• Increased risks for opioids: concern for hemodynamic or respiratory depression effects of 
opioids, opioid addiction relapse, opioid tolerance, or use of opioid abuse/addiction treatment 
medication (eg. methadone). 
• Ketamine IV preferred when possible as slow infusion decreases adverse effects. 
• Consider other non-opioids before ketamine and opioids if allowed by existing protocols. 
• No minimum pain requirement for ketamine due to subjective nature of pain reporting. 
However, adverse effects should be weighed against pain severity and discomfort.       
Yes 
Yes 
Yes 
Yes Yes 
No 
No 
 No 
 No 
 No 
 No 
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Limitations and Future Research 
 There are several limitations of this thesis. This is a literature review and no 
prospective research was conducted. As such, the thesis is dependent on the quality of the 
results and information contained in the current published literature. This was also not a 
rigorous meta-analysis and the literature presented in the report of current literature does 
not represent every published study. Publications that were not available in English and 
publications that could not be accessed in full were not used in the Report of Current 
Literature section of this thesis, with one exception. There were two subgroup analysis 
publications that were only accessible in abstract (Coffey et al., 2018a, 2018b). However, 
these abstracts were used in the report of current literature as the initial study was 
available in full.  
Care was taken to consider high quality evidence, but there were various 
limitations and weaknesses present in the reported literature. The first major limitation 
was the paucity of EMS research, especially regarding pain management. Secondly, the 
inherent difficulty of objectively measuring a patient’s pain, which is itself a largely 
subjective process, further impedes research on this subject. The subjective nature of pain 
and adequate pain control also increases the difficulty of establishing clinically relevant 
outcome measures. Other limitations specific to each study were discussed in the 
Limitations in Reported Literature section and taken into consideration when making 
conclusions. However, the ability to generalize the results of the published literature to 
EMS further limited the conclusions that could be supported. Multimodal analgesia is 
another important consideration in pain management. However, this thesis specifically 
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investigated single agent comparisons. Due to these various limitations, the conclusions 
made in this thesis should not be relied on as the sole source of information when 
selecting an analgesic to administer. Rather, this thesis should provide a guide used as a 
part of the decision-making process to select an appropriate analgesic. 
Given the importance of pain management in EMS and the high rates of 
inadequate pain management, research in this topic should continue being performed. It is 
evident that more EMS specific research is required. There are several topics of research 
that should be conducted or expanded on given the information noted in this thesis. More 
comprehensive outcome measures that better represent the complex and subjective nature 
of the pain experience should be investigated. Special attention should be given to the 
identification of adequate pain management, while considering the current 
recommendations that goals should be patient specific, realistic, and consider the many 
complex factors at play in a patient’s pain experience. Those outcome measures should 
then be utilized in future research endeavors to allow for the most clinically relevant 
results and comparison between studies. Those future endeavors should include a patient 
population that covers a wider range of the patients treated by EMS for acute pain. There 
is also a need for research into the pediatric patient population. These research studies 
should include investigating the efficacy of different analgesics and comparisons between 
various analgesics in the diverse EMS specific patient population.  
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CONCLUSION 
 The high prevalence of acute pain reported in EMS patients, the lack of adequate 
pain management reported, and many calls to improve analgesia have made the 
importance of this topic clear. The severity of the opioid epidemic has placed additional 
pressures on healthcare providers at all scopes of practice to utilize opioid alternatives 
while attempting to improve the quality of pain management provided to patients. This 
literature review sought to determine if non-opioid analgesics can be utilized as first line 
treatment for EMS patients with acute pain.  
Due to the paucity of research relevant to this topic, a general recommendation for 
non-opioid analgesics cannot be supported. However, more specific suggestions can be 
supported by the reported literature. In addition to existing recommendations that 
NSAIDs be used as first line treatment for patients with acute renal colic pain, this 
literature review supports the use of acetaminophen over opioid analgesics for these 
patients. The use of acetaminophen, ketorolac, and nitrous oxide as first line treatment by 
EMS for patients with acute pain resulting from an isolated extremity trauma is also 
supported. 
Some conclusions regarding ketamine were also supported. Specifically, in 
pediatric patients with an acute extremity injury, EMS should consider ketamine over 
opioid analgesics. A more general and stronger suggestion can be made for adult patients. 
Ketamine should be considered by EMS for use as first line treatment over opioid 
analgesics. Both ketamine conclusions are strengthened in patients where opioid 
addiction relapse, opioid dependence, or the negative hemodynamic and respiratory drive 
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effects of opioid analgesics are of heightened concern. Patients in extremis and patients 
below the age of 16 years old are not well represented and are excluded from all these 
conclusions, except for the pediatric specific suggestion for ketamine.  
An EMS protocol was proposed that summarized the recommendations and 
considered the important applicability aspects discussed. Potential implications of both 
exclusive opioid analgesic use and non-opioid analgesic use by EMS were also 
considered. The importance of EMS education, in addition to non-opioid protocols, was 
discussed. It is important to note that a suggestion for first-line treatment is not 
suggesting exclusive or sole use of that analgesic. It is only suggesting that it be 
considered first, prior to other analgesics. This thesis provides a guide to be used as a part 
of the decision-making process to select an appropriate analgesic rather than the sole 
source informing the decision. Due to the paucity of research, further research on this 
important topic may either strengthen or disprove one or more of these conclusions and is 
needed to improve the quality of acute pain management provided by EMS.  
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